Studies on the structure and function of phenazine modifying enzymes PhzM and PhzS involved in the biosynthesis of pyocyanin by Gohain, Neelakshi
Studies on the structure and function of 
phenazine modifying enzymes PhzM and 
PhzS involved in the biosynthesis of 
pyocyanin 
 
DISSERTATION 
 
zur Erlangung des akademischen Grades 
eines Doktors der Naturwissenchaften (Dr. rer. nat.) 
des Fachbereichs Chemie der Universität Dortmund 
 
Angefertigt am Max-Planck-Institüt für Molekulare Physiologie 
In Dortmund 
 
Eingereicht von 
 
Neelakshi Gohain 
Aus Mumbai/Indien 
 
Dortmund, 2008 
 
1. Gutachter :                                                          Prof. Dr. R.S.Goody 
 
2. Gutachter :                                                          Prof. Dr. H.Mootz 
 
 
 
 a
Studies on the structure and function of 
phenazine modifying enzymes PhzM and 
PhzS involved in the biosynthesis of 
pyocyanin 
 
 
DISSERTATION 
 
Submitted towards partial fulfillment of requirement 
for the degree of 
 
DOKTOR DER NATURWISSENCHAFTEN 
(DR. RER. NAT.) 
 
in the Department of Chemistry, 
University of Dortmund, Germany 
 
By  
Neelakshi Gohain 
Max Planck Institute for Molecular Physiology 
 
& 
Department of Chemistry, University of Dortmund  
 
 
2008 
 b
 
Die vorliegende Arbeit wurde in der Zeit von September 2004 bis September 2008 am 
Max- Planck-Institut für Molekulare physiologie in Dortmund unter der Anleitung von 
Prof. Dr. Roger S Goody, Dr. Wulf Blankenfeldt und Prof. Dr. H.Mootz durchgeführt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hermit versichere ich an Eides statt, dass ich die vorliegende Arbeit selbständig und nur  
mit den angegeben Hilfsmitteln angefertigt habe.  
  
 
 
Dortmund, 2008                                                                                        Neelakshi Gohain 
 
 
 c
 d
 
 
 
 
 
 
 
Dedicated to my mother… 
 
 
 
 
 
 
 
 
 
 
CONTENTS 
 
Contents                                                                                                                i 
Symbols and Abbreviations    iv 
 
1.0 INTRODUCTION 
 
1.1  Introduction to phenazines                                                                      2 
1.2          Occurrence of phenazine production                                                      3 
               1.2.1    Pyocyanin 5 
                           1.2.1.1    Chemical nature of pyocyanin 5 
                           1.2.1.2    Ill effects of pyocyanin 8 
1.3          Chemical properties of phenazines 9 
1.4          Mode of action                                                                                       10 
1.5          Biosynthesis of phenazines                                                                   12 
1.6          Assembly of the tricyclic phenazine ring scaffold 17 
1.7          Genetic basis of phenazine biosynthesis in pseudomonads 18 
               1.7.1    Phenazine biosynthesis in Pseudomonas 19 
1.8          Enzymes of the phenazine biosynthesis operon 20 
               1.8.1    Phenazine modifying enzymes 23 
               1.8.2    AdoHcy nucleosidase 25 
               1.8.3    Biosynthesis of pyocyanin 26 
1.9          Regulation of phenazine biosynthesis 28 
 
  
2.0 OBJECTIVES OF THIS WORK 32 
 
3.0 MATERIALS AND METHODS                                                                         
 
3.1          Materials 34 
               3.1.1 Chemicals 34 
 3.1.2    Materials 34 
 3.1.3     Kits 34 
 3.1.4    Microorganisms 35 
 3.1.5 Plasmid vectors 35 
               3.1.6    Media and antibiotics 35 
 3.1.7    Buffers 36 
3.2 Competent cells and transformation 36 
 3.2.1    Transformation by heat shock 37 
 3.2.2    Transformation by electroporation 38 
3.3 Protein Overexpression and purification 38 
 3.3.1    Protein expression 38 
 3.3.2    Protein purification 38 
 3.3.3    SDS-PAGE 39 
 3.3.4    Size exclusion chromatography 39 
 3.3.5    Determination of protein concentration 40 
 3.3.6    Final concentration and storage of protein 40 
 3.3.7    Seleno-L-methionine labelled protein 40 
 3.3.8    High Pressure Liquid Chromatography (HPLC) 41 
 i
3.4 Methods for protein analysis 41 
 3.4.1    Isothermal Titration Calorimetry (ITC) 41 
 3.4.2    Mass Spectrometry 43 
 3.4.2.1    HPLC-APCI-MS 44 
 3.4.2.1.1    HPLC 45 
 3.4.2.1.2    APCI 46 
 3.4.2.1.3    Reaction Mixture for HPLC-APCI-MS 47 
 3.4.3    UV-VIS Spectroscopy 48 
3.5 Crystallographic Methods 49 
 3.5.1    Crystallisation by Vapour-Diffusion 53 
 3.5.2    Selecting a cryoprotectant 54 
 3.5.3    Data collection and processing 55 
 3.5.3.1    Data Collection 56 
 3.5.3.2    Data Processing 57 
 3.5.4    Determination of Phases 59 
 3.5.5    Model Building and Refinement 61 
 
 
4.0 RESULTS & DISCUSSIONS 
 
4.1 Cloning, over-expression and purification 64 
 4.1.1    PhzM 64 
 4.1.2    PhzS 65 
 4.1.3    S-adenosylhomocysteine nucleosidase  66 
4.2 Crystallisation 67 
 4.2.1    PhzM 67 
 4.2.2    PhzS 69 
4.3 Data collection, Structure Determination & Quality of Model 70 
 4.3.1    PhzM and PhzM complexed with SAM 70 
 4.3.2    PhzS 74 
4.4 Structural Analysis 78 
 4.4.1    Structural Analysis of PhzM from Pseudomonas aeruginosa 78 
 4.4.1.1    Monomer of PhzM 78 
 4.4.1.2    Dimer of PhzM and dimer interface 81 
 4.4.1.3    PhzM and the homologues structures 82 
 4.4.1.4    SAM binding site or the C-terminal domain 83 
 4.4.2    Structural Analysis of PhzS from P. aeruginosa 86 
     4.4.2.1    Monomer of PhzS 87 
 4.4.2.2    The Rossmann fold 89 
 4.4.2.3    Dimer of PhzS and dimer interface 93 
4.4.2.4 PhzS and the homologues structure                             95 
4.4.2.5 Getting an idea about substrate binding in PhzS from  
the function of 1PHH                                                    97 
 
4.5 Biochemical Analysis of proteins 100 
 4.5.1    ITC  100 
 4.5.2    HPLC-APCI-MS 101 
 4.5.2.1    Pyocyanin biosynthesis                                               102 
 
 
 ii
5.0            Summary                                                                                              110 
 
6.0            Outlook                                                                                                 116 
 
7.0 References                                                                                            119 
 
8.0 Acknowledgements                                                                              132 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii
SYMBOLS AND ABBREVIATIONS 
 
 
Å Ångstrom (0.1nm) 
CAN Acetonitrile 
ADIC 2-amino-2-deoxychorismic acid  
AdoHcy S-Adenosyl-L-Homocysteine 
APCI Atmospheric Pressure Controlled 
Ionization 
APS Ammonium Persulfate 
bp base pair 
BSA Bovine Serum Albumin 
CCD Charge Coupled Devices 
C-terminus Carboxyterminus 
Da Dalton 
DMSO Dimethyl Sulfoxide 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
EDTA Ehtylendiamintetraacetate 
ESRF European Synchrotron Radiation 
Facility 
E. coli Escherichia coli 
ESI-MS Electrospray Ionisation Mass 
Spectroscopy 
Fcalc, Fobs Structure-factor amplitudes 
(calc:calculated, obs: observed) 
FAD Falvin Adenine Dinucleotide 
FPLC Fast Performance Liquid 
Chromatography 
GC Gas Chromatography 
1-oh-phz 1-Hydroxy Phenazine 
HPLC High Performance Liquid 
Chromatography 
IPTG Isopropyl-β-D-1-thiogalactopyranosid 
ITC Isothermal Titration Caloriemetry 
kb kilo-base pair 
kDa kilo-Dalton 
kJ kilo-Joule 
LB Luria-Bertani 
λ Wavelength, Lambda 
MAD Multiple Wavelength Anomalous 
Dispersion 
MALDI Matrix Assisted Laser 
Desorption/Ionization 
Min Minute 
 iv
MIR Multiple Isomorphous Replacement 
MM Millimolar 
MR Molecular Replacement 
Mw Molecular Weight 
NADH Nicotinamide Adenine Dinucleotide 
NADPH Nicotinamide Adenine Dinucleotide 
Phosphate 
NCS Non-Crystallographic Symmetry 
Nm Nanometer 
NMR Nuclear Magnetic Resonance 
N-terminus Aminoterminus 
O.D Optical Density 
P.aeruginosa Pseudomonas aeruginosa 
PCA Phenazine-1-carboxylic acid 
PCR Polymerase Chain Reaction 
PDB Protein Data Bank 
PDC Phenazine-1,6-dicarboxylic acid 
PEG Polyetheleneglycol 
PMSF Phenylemethylsulphonylfluoride 
Pyo Pyocyanin 
RNA Ribonucleic acid 
Rmsd Root mean square deviations 
RT Room temperature 
SAM S-Adenosyl methionine 
SAD Single-Wavelength Anomalous 
Dispersion 
SDS-PAGE Sodiumdodecylsulphate-
Polyacrylamide Gel Electrophoresis 
Se Selinium 
SeMet Seleno-L-Methionine 
TB Terrific Broth 
TEMED N,N,N,N -Tetramethyl-
Ethylenediamine 
TFA Trifluoro acetic acid 
TRIS Tris-(hydroxymethyl)-aminomethane 
U Units 
UV Ultraviolet 
V Volt 
µl Microliter 
µM Micromolar 
 
 
 
 
 v
 vi
 
Amino Acids Abbreviations 
 
 
 
Amino Acids 
 
3-letter-code 
 
1-letter Code 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartate Asp D 
Cysteine Cys C 
Glutamine Glu E 
Glutamate Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Phenylalanine Phe F 
Methionine Met M 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophane Trp W 
Tyrosine Tyr Y 
Valine Val V 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
INTRODUCTION 
1.0 Introduction  
 
1.1 Introduction to phenazines 
 
For more than a century, chemists have been concerned with the discovery, 
isolation, and characterization of chemical substances in the earth’s biota. 
That the inventory is not yet complete becomes apparent from perusal of any 
journal recording current research on natural products. New substances 
continue to be discovered in substantial numbers. By, and large, these do not 
fit into the well-established systems for intermediary metabolism, and so add 
to that diverse collection of compounds called secondary metabolites, a term 
invented by plant physiologists (1) and brought into general use for microbial 
products by J. D. Bu’Lock in 1961 (2). Historically, microbiologists and 
chemists alike have categorized 'secondary metabolites' as a broad class of 
molecules produced at late stages of microbial growth in laboratory cultures. 
In particular, the traditional view is that secondary metabolites (i) do not 
contribute to the growth or survival of the producer (ii) are highly sensitive to 
the conditions stimulating their production (for example, medium composition) 
(iii) often have complex structures and (iv) have production rates that are 
decoupled from the doubling time of the cells (3). Secondary metabolites have 
diverse chemical structures, and their intricate molecular frameworks often 
appear to the biochemist to be quite idiosyncratic. They are usually distinctive 
products of particular groups of organisms sometimes even of a single strain.  
 
Amongst the secondary metabolites that have gained interest in 
pharmaceutical and clinical research groups for the last 50 years is a class of 
compounds called ‘phenazines’. They are heterocyclic nitrogen-containing 
compounds synthesized by some strains of fluorescent Pseudomonas species 
and some other bacterial genera. Phenazine-excreting bacteria have become 
popular model organisms for the study of quorum sensing and biofilm 
formation, two of the most active areas of research in the field of microbiology, 
whereas pharmaceutical and clinical groups have been focused on the 
physiological effects of these compounds in non-producing organisms, 
microbial physiologists and geneticists have typically  
 2
INTRODUCTION 
viewed phenazines as metabolites that perform only secondary functions. 
That phenazines and other excreted compounds (i) react with common 
primary metabolites (ii) are potentially transformed by enzymes active in 
central metabolic pathways and (iii) induce gene expression calls into 
question their categorization as secondary metabolites (4). Here I will discuss 
the recent discoveries that lead to new hypotheses about the relevance of 
phenazine metabolism in the context of the lifestyles of their producers. 
 
 
 
 
Fig1.1. Some phenazine derivatives 
 
1.2 Occurrence of Phenazine Production: 
 
The discovery of phenazines dates back to as early as 1860 when French 
researchers and clinicians noticed a blue coloration in the pus and sputum, or 
respiratory secretion, of infected patients (5). In 1882 Carle Gessard and 
others examined the pus microscopically and identified a rod-shaped 
bacterium residing in these wounds, and upon isolating the organism 
discovered that it was responsible for the bluish tint. For this trait, they named 
the species Bacillus pyocyaneus, and it has since been renamed 
Pseudomonas aeruginosa, for the Latin aerugo, which refers to the blue-green 
rust of copper. The antibiotic properties of phenazines have been known for 
over 150 years, but it is only within the past few years that significant progress 
 3
INTRODUCTION 
has been made in understanding how these compounds are synthesized, how 
they affect other organisms, and how they function in the environment. 
Phenazines are nitrogen containing heterocyclic compounds produced by 
diverse bacterial genera, including Erwinia, Burkholderia, Streptomyces and 
fluorescent Pseudomonas species under quorum sensing control. Of more 
than 6000 phenazine-containing compounds that have been described over 
the past century, fewer than 100 are of natural origin, but most of these 
possess broad-spectrum antibiotic activity toward bacteria, fungi, and plant 
and animal tissues (6). Most studies on the production and biosynthetic 
pathways of the various phenazine pigments have been conducted with the 
representatives of the fluorescent pseudomonads. Pseudomonads represent 
the major group of non-differentiating microorganisms producing antibiotics. 
The lack of cytological and physiological differentiation makes it possible to 
study the effect of various factors on secondary metabolism without 
interference from genetically programmed development cycles. The 
pseudomonads may therefore offer experimental advantages over the 
filamentous fungi, the actinomycetes, and the bacilli for studying certain facets 
of secondary metabolism (T.Leisinger and R.Margraff 1979). The practical use 
of antibiotics from pseudomonads date back to the period before the ‘antibiotic 
era’. In 1899 some researchers reported that the cell free culture fluid of P. 
aeruginosa, concentrated to one-tenth of its original volume, killed several 
kinds of bacteria. It has been used extensively in the therapy of diphtheria, 
influenza, and meningitis during the first two decades of this century (7). 
 
Phenazine-producing species are more abundant among the high G+C Gram-
positive lineage, but they also occur within two clades of Gram-negative 
Proteobacteria. All known phenazine-producing Gram-positive bacteria are 
Actinobacteria. Many are members of the genus Streptomyces, with over a 
dozen species that synthesize both simple and more complex phenazines 
(6).Amongst all phenazine producing fluorescent pseudomonads bacteria 
Pseudomonas aeruginosa has been most widely studied because it is a 
ubiquitous environmental bacterium that is one of the top three causes of 
opportunistic human infections that is, it exploits some break in the host 
defences to initiate an infection (8-10). One of the reasons why P. aeruginosa 
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is a successful opportunistic pathogen is that it produces a battery of secreted 
virulence factors (11). The bacterium almost never infects uncompromised 
tissues, yet there is hardly any tissue that it cannot infect if the tissue 
defences are compromised in some manner. It causes urinary tract infections, 
respiratory system infections, dermatitis, soft tissue infections, bacteraemia, 
bone and joint infections, gastrointestinal infections and a variety of systemic 
infections. Pseudomonas aeruginosa infection is a serious problem 
particularly in patients hospitalized with cancer, cystic fibrosis, severe burns 
and AIDS patients who are immunosuppressed (12;13) Apart from this the 
antibiotic activity of the secondary metabolites produced by P.aeruginosa 
made its investigation more interesting in the scientific research field. In 1899 
Emmirich and Low reported that the cell free culture fluid of P.aeruginosa, 
concentrated to one-tenth of its original volume, killed several kinds of 
bacteria. Because the preparation exhibited enzymatic activities, it is called 
pyocyanase. It has been used extensively in the therapy of diphtheria, 
influenza and meningitis during the first two decades of 20th century 
(T.Leisinger and R.Margraff 1979). Pseudomonas aeruginosa strains produce 
two types of soluble pigments, the fluorescent pigment pyoverdin and the blue 
pigment pyocyanin. The latter is produced abundantly in media of low-iron 
content and functions in iron metabolism in the bacterium (14). Pyocyanin 
(from "pyocyaneus") refers to "blue pus" and is a characteristic of suppurative 
infections caused by Pseudomonas aeruginosa. My work mainly deals with 
giving an insight to the biosynthesis of pyocyanin. 
 
1.2.1. Pyocyanin 
1.2.1.1 Chemical nature of pyocyanin 
Pyocyanin is a blue redox-active secondary metabolite and a member of the 
large family of the tricyclic compounds ‘phenazines’ (13). Because of its 
solubility in chloroform it can be easily isolated. Pyocyanin or 1-hydroxy-5-
methylphenazine is considered as a resonance hybrid of the mesomeric forms 
of N-methyl-1-hydroxyphenazine (Hillemann, 1938) (15) and is capable of 
undergoing a two-electron reduction to a colourless product, leukopyocyanin. 
The elucidation of the structure of pyocyanin represents the first reported 
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instance of the occurrence of the phenazine nucleus as a natural product (16). 
Pyocyanin can exist in either oxidized or reduced form, the later being an 
unstable form of pyocyanin that reacts rapidly with molecular oxygen (17). The 
pigment is wine-red at acid condition due to the basic property of one of the N 
atoms and blue at alkaline reaction (Friedheim et al 1931). 
 
Fig 1.2 (a) Structure of pyocyanin 
 
 
 
 
 
 
Fig 1.2. (b) colours of pyocyanin in acid and alkaline solution (c) the intermediary 
green colour 
 
When the alkaline blue solution is reduced, say by a trace of colloidal 
palladium in a stream of hydrogen, the colour vanishes and is reestablished 
on exposure to the air. However, when the acid red form of the pigment is 
reduced there is an intermediary green stage (fig. 1.2(c)) before the complete 
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decolouration. In the same manner when the completely reduced colourless 
form of the pigment is titrated with a colourless oxidant (such as ferricyanide) 
in an alkaline solution, the colourless form directly turns blue, whereas in an 
acid solution the colour first turns green and just when the half of the 
equivalent amount of the oxidant is being exceeded (judged from the 
potentiometric end-point of titration) begins to turn red (Friedheim et al 1931). 
 
 
 
 
 
 
 
Fig 1.3 The normal potential of pyocyanin at varied pH at 30°c (Friedheim and L. 
Michaelis Journal of biological chemistry Feb, 1931) 
 
The blue pigment pyocyanin is reversibly oxidizable and reducible. In ranges 
of pH>6 it behaves entirely as a reversible dye of a quinoid structure. The 
slope of the titration curve indicates that one molecule of the dye combines 
with two hydrogen atoms simultaneously. At pH ranges<6 the titration curves 
show a different shape which can be interpreted by the assumption that the 
two hydrogen atoms are accepted in two separate steps. The existence of 
these two steps of reduction is confirmed by the fact that in acid reaction the 
colour, on reduction, changes in two different steps, whereas at alkaline 
reaction the color change takes place in one step as mentioned earlier. The 
normal potentials of the dye at various pH are summarized in Fig. 1.3. 
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1.2.1.2 Ill effects of pyocyanin  
Pyocyanin is toxic at micro molar concentrations to a wide range of bacterial 
and mammalian cells. In vivo virulence of pyocyanin was studied on 
alternative model hosts and mice, which revealed that pyocyanin has crucial 
role in P. aeruginosa infection. It causes multiple and omnious effects on 
human cells like inhibition of cell respiration (18), ciliary function (19), 
epidermal cell growth and disruption of calcium homeostasis. It may interact 
with endothelium derived relaxing factor nitric oxide (20), which plays an 
important role in the control of blood pressure, blood flow and immune 
function, through the formation of a complex or it may act by inhibition of nitric 
oxide synthase (21). It also inactivates the α1 protease inhibitor (22) and 
contributes to the imbalance of protease–antiprotease activity, which is readily 
detected in the airways of patients with Cystic Fibrosis lung disease. It has 
been shown recently that P. aeruginosa strains with defective pyocyanin 
biosynthesis are less virulent and more susceptible to the immune response in 
the lung infection mouse model (23). Pyocyanin can increase oxidant 
formation in human airway epithelial cells through a number of mechanisms 
including the oxidation of glutathione and NADH and inhibition of antioxidant 
enzymes. Once it is reduced, pyocyanin can then react with oxygen, forming 
superoxide radical and hydrogen peroxide (24). Pyocyanin radical is also 
formed as an intermediate during its redox cycling and can then further 
contribute to the formation of reactive oxygen species (ROS) (25). These 
insults to the host cell’s internal redox balance may lead to increased 
secretion and thereby contribute to the generation of sputum, the physical and 
nutritional substrate for P.aeruginosa in the lungs of individuals with Cystic 
Fibrosis.  
 
Bacteria of the genus Pseudomonas, like most heterotrophic bacteria (26), 
oxidize organic carbon sources via the activity of the citric acid cycle. Several 
of the oxidative steps in these pathways are coupled to the reduction of NAD+ 
to NADH, and NADH must be reoxidized so that these pathways can proceed 
and generate anabolic precursors. In pseudomonads, the primary mechanism 
whereby this is accomplished is through reduction of one of the NADH 
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dehydrogenases at the start of the respiratory chain, which ultimately transfers 
the electrons to oxygen or nitrate (27). It has therefore been assumed that 
pseudomonads, organisms that rely on respiration for growth under most 
conditions, accumulate NADH when terminal electron acceptors become 
limiting (28). Some of these compounds, including pyocyanin, the best-studied 
phenazine due to its role in the pathology of P. aeruginosa infections, have 
been shown to react with NADH in vitro (29;30). This has led to the hypothesis 
that electron transfer to phenazines may represent an adaptation that allows 
bacteria to modulate their intracellular redox state (31;32). This physiological 
role would be consistent with the fact that phenazine biosynthesis is regulated 
such that phenazines are produced at high cell densities (33-35), a condition 
that typically correlates with electron acceptor limitation (36). Friedheim 
theorised that the reducible nature of pyocyanin was important for the 
respiration of P.aeruginosa because addition of pyocyanin could function as 
an extracellular respiratory pigment. In human alveolar epithelial cells, 
pyocyanin causes oxidative stress accompanied by direct inhibition of 
catalase, depletion of cellular cAMP and ATP, and depletion of the 
intracellular pool of reduced glutathione (GSH) that serves as a major 
antioxidant (37); (38). Instead of acting as a protectant under these conditions, 
GSH can further enhance the damage to lung tissues by reducing pyocyanin 
with the production of pyo free radical and O2-.(6). 
 
1.3. Chemical properties of Phenazine  
 
Phenazines are heterocyclic compounds that are produced naturally and 
substituted at different points around their rings by different bacterial species. 
Small modifications of the core phenazine structure give rise to a full spectrum 
of colours (Fig 1.4), ranging from the deep red of 5-methyl-7-amino-1-
carboxyphenazinium betaine (aeruginosin A) to the lemon yellow of 
phenazine-1-carboxylic acid (PCA), to the bright blue of 1-hydroxy-5-
methylphenazine (pyocyanin) (39). The combination and variety of functional 
groups added also determine the redox potential and solubility of these 
compounds, thus affecting their biological activity (40). Early studies on 
phenazines were motivated by the fact that phenazines possess broadband 
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antibiotic activity towards other microorganisms (41). Most of the phenazines 
produced by Pseudomonas species are simply carboxy- and hydroxyl- 
substituted derivatives but their physical properties and consequently the 
antibiotic activity differ according to the nature and position of the substitutents 
on the heterocyclic ring. The lack of obvious metabolic functions of 
phenazines has led to several hypotheses on their role in nature. As 
phenazine-producing organisms survive longer than non-phenazine-producing 
species, it is likely that the phenazine production, due to the apparent 
antibiotic activity, helps the producing organism to protect its habitat against 
other microbial competitors. Apart from this leukopyocyanin has the ability to 
reduce iron and causes the release of iron from transferrin, a protein that 
normally sequesters iron so that it is available only to the human host (17). 
Thus, phenazine reduction could act to make the iron more available to the 
producing organism. 
 
a b 
 
Fig.1.4. (a) Streak plate of the bio-control strain P. aureofaciens 30-84. The 
phenazine 2-OH-PCA turns the agar bright orange. (b). Aqueous solutions of some of 
the phenazines produced by various Pseudomonas strains (42). 
 
1.4. Mode of Action 
 
The biological activities of phenazines have interested chemists for a long 
time and an estimated 6000 phenazine compounds have been synthesised or 
modified after their discovery from biological sources. These include 
chemically synthesised phenazines which play an important role in physical 
and electrochemical research, e.g. construction of microbial fuel cells for 
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generation of renewable energy source (43). Additionally, phenazines were 
designed to exploit their DNA intercalative properties, e.g. [5,4-ab]-phenazine 
and phenazine-5,10-dioxide to investigate their anti-proliferative, thus anti-
tumour and anti-cancer activities (44-46). Among the models that have been 
advanced to explain the unusually broad activity of phenazines, those that 
remain the focus of contemporary research involve interactions with 
polynucleotides, topoisomerase inhibition and the generation of free radicals 
(6). Although the exact mechanism of intercalation of DNA by phenazines is 
not well understood, it is thought that phenazines act by hindering DNA 
biosynthesis, replication or processing (47). These examples clearly indicate 
that phenazines, rather than performing one dedicated purpose, seem to be 
capable of performing multiple roles. This has led to intensification in research 
towards understanding the mode of action of phenazines. The evident non-
selective toxicity of phenazines was thought to arise from a mode of action 
directed against one of the more universal primary metabolic pathway 
reactions (48). In 1934, Friedheim and co-workers showed through 
potentiometric study that pyocyanin in mixture with its reduced derivative 
acted as a reversible redox system.  
Almost all the effects of phenazines mentioned in the previous paragraph 
(except DNA intercalation) can be attributed to this one essential feature of 
phenazines - their capacity for undergoing redox transformations (24;49-51). 
Phenazines are thought to diffuse across or insert into membranes and readily 
undergo redox-cycling in the presence of molecular oxygen, resulting in the 
uncoupling of oxidative phosphorylation and generating reactive oxygen 
species like superoxide (O2-.) hydroxyl (OH-) and hydrogen peroxide (H2O2) 
(24;41) (Fig 1.5).  
The accumulation of these radicals is toxic not only to bacterial but also fungal 
and eukaryotic cells (52;53) thus conferring host-nonspecific pathogenicity to 
organisms producing phenazines. The finding of Friedheim about increased 
rates of respiration has been reiterated by O’Malley et al., (54) and Lau et al. 
(55;56), who showed that the effects of PCA and PYO on both bacterial and 
eukaryotic host cells result from oxidative activity and the inactivation of 
proteins involved in oxidative stress responses. Moreover, Hassett and co-
workers (53;57) have found that the superoxide dismutases of pyocyanin 
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producing P. aeruginosa possess a higher activity than other known 
dismutases, which would protect this organism from the harmful effects of 
phenazines.  
 
 
 
 
 
 
 
Fig1.5 Phenazine reduction and auto-oxidation (58) 
Though the redox activity of phenazines is well known and the mode of action 
is hypothesised, the exact mechanism of how phenazines generate these 
species is not well understood. A more detailed understanding of mode of 
action of various phenazines, their influence on the molecular level and their 
metabolism is only just emerging (59;60). 
 
1.5. Biosynthesis of Phenazines 
 
All secondary metabolites are known to arise from some modification of the 
primary metabolic pathways of cells. The shikimate pathway is an essential 
metabolic route by which microorganisms and plants synthesise the aromatic 
amino acids phenylalanine, tyrosine and tryptophan, as well as a number of 
other aromatic compounds, which are critical to sustaining the primary 
functions of living organisms. It links the metabolism of carbohydrates to the 
biosynthesis of ring containing compounds (61). The absence of this pathway 
in animals makes it an attractive target for metabolic intervention in the 
development of chemotherapeutic agents as well as herbicides. However, the 
significance of the shikimate pathway extends well beyond the manufacture of 
these primary cellular metabolites. The pathway is also the source of a vast 
number of secondary metabolites of plants and microorganisms, natural 
products which, although not critical to the immediate survival of the producing 
organism, help it in a variety of ways to maintain its position in its ecological 
environment (62). The majority of these shikimate-derived natural products 
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are formed from the end products of the shikimate pathway, i.e. the aromatic 
amino acids (63). 
 
 
Fig 1. 6.The Shikimate Pathway (www.biologie.uni-hamburg.de/b-online/ge19/26.gif) 
 
 13
INTRODUCTION 
The discovery of the Shikimic acid pathway for the biosynthesis of aromatic 
amino acids - tryptophan, tyrosine and phenylalanine in the 1960s (Balinsky 
and Davis, 1961) and the availability of isotopically labelled compounds 
resulted in the investigation of some metabolic intermediates of the shikimate 
pathway as a possible precursor. Information on the assembly of the first-
formed phenazine from a derivative of shikimate has been obtained from the 
elegant studies by Hollstein & McCamey (64) and Herbert et al. (1974, 1976) 
of iodinin biosynthesis (65). 
Three important studies in the 1960-70 period established beyond doubt that 
the Shikimic acid pathway was indeed the primary metabolic pathway which 
branched into the phenazine biosynthesis. The first of these studies was 
carried out in 1963 by Millican (66) and showed that biosynthetically prepared 
[U14-C] shikimic acid was the precursor of pyocyanin synthesised by P. 
aeruginosa; with the recovery of around 16% of this radiolabelled shikimate in 
pyocyanin. A second set of experiments using isotope-competition technique 
(67;68) confirmed that shikimic acid was the precursor for biosynthesis not 
only of pyocyanin but also phenazine-1-carboxylic acid and oxychlororaphin.  
 
 
Fig. 1.7 Shikimate to chorismate and then to phenazines and to aromatic amino acids  
 
Lastly, experiments by Longley et al. and Calhoun et al., (1972) used mutants 
unable to degrade shikimic acid and blocked at various points on the 
branched pathway to aromatic amino acids. Their experiments not only 
validated the conclusions by the previous two sets of experiments, but went 
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further and identified chorismic acid as the branching point of the shikimic acid 
pathway to phenazine biosynthesis (Figure1.7).  
 
The next question in elucidating the phenazine biosynthesis pathway was the 
identification of the compound that led to the formation of the tricyclic scaffold 
of phenazines. 
 
 
 
 
 
 
Fig. 1.8 (a) 
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Fig. 1. 8(a) & (b) The proposed intermediates of the phenazine biosynthesis pathway 
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1.6. Assembly of the tricyclic phenazine ring scaffold 
Initial studies on Iodinin led to the hypothesis that the phenazine moiety was 
formed by the diagonal, asymmetrical incorporation of two shikimic acid units. 
4,9-dihydroxyphenazine-1,6-dicarboxylic acid was hence proposed as the key 
intermediate in the biosynthesis of all phenazines (69). 
The biosynthesis of phenazines has been extensively studied in 
Pseudomonas species, particularly by the groups of Herbert and of Hollstein. 
The Shikimate origin of the phenazine skeleton in these organisms was amply 
demonstrated by feeding experiments with labelled precursors. These gave 
good incorporations of shikimic acid into the phenazine skeleton, they showed 
that both halves of the phenazine ring are labelled by shikimic acid and they 
demonstrated the coupling mode shown in Fig. below by which two molecules 
of shikimic acid are linked to each other to give the phenazine ring system. 
 
Fig 1.9 Shikimic acid to the phenazine ring system 
 
Meanwhile, search continued for more evidence for chorismic acid being the 
compound that dimerises to form the phenazine ring system, with anthranilic 
acid also being considered. The discovery of two sets of anthranilate synthase 
genes in pyocyanin producing strains of P. aeruginosa by Essar et al., (1990) 
gave some credence to this hypothesis, although all previous attempts to 
demonstrate incorporation of isotopically labelled anthranilate into phenazine 
were unsuccessful (70;71). Thus, although the shikimic acid pathway was 
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accepted as the primary metabolic pathway, which branched off into 
phenazine biosynthesis, the mechanism of assembly of the tricyclic scaffold of 
phenazines and identity of the intermediate formed in this process remained 
unclear. 
 
1.7.Genetic basis of phenazine biosynthesis in 
pseudomonads 
 
Further progress in understanding the phenazine biosynthesis pathway came 
in 1995, when Pierson and co-workers identified the biosynthetic genes 
responsible for the production of phenazine in P. aureofaciens (72). Soon, a 
phenazine biosynthesis locus was also identified, cloned and sequenced in P. 
fluorescens (73) and P. aeruginosa (74). This locus comprised of a conserved 
seven-gene operon phzABCDEFG, which was found to be sufficient for the 
production of PCA from chorismic acid. (Fig. 1.9). Both P. aureofaciens and P. 
fluorescens contain one, whereas P. aeruginosa possesses two copies of the 
phenazine biosynthesis operon. PCA is the end product of this ‘core’ 
phenazine biosynthesis pathway. 
8505bp
 
Fig. 1.10 Phenazine biosynthesis operon from Pseudomonas fluorescens 2-79 
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The discovery of this ‘core’ phenazine biosynthesis operon in Pseudomonas 
led to further investigation into the presence of this operon in other phenazine 
producing species. 
 
1.7.1. Phenazine biosynthesis in Pseudomonas 
 
McDonald et al., (2001) expressed all or a subsets of the seven genes of the 
phenazine biosynthesis operon of P. fluorescens in Escherichia coli. Feeding 
experiments were then carried out using exclusively, chorismic acid, 
anthranilic acid or 2-amino-2-deoxychorismic acid (ADIC), to re-examine the 
branching point of phenazine biosynthesis from the shikimic acid pathway and 
the process of phenazine ring assembly. 
 
Their results proved conclusively that chorismic acid was the branching point 
and that it was converted to 2-amino-2-deoxychorismic acid (ADIC) by the 
enzyme PhzE. Also, neither anthranilic acid (no conversion to PCA) nor 
chorismic acid (conversion to ADIC by PhzE, but no PCA formation) were 
utilised for the assembly of the phenazine scaffold. ADIC however, was 
completely converted to PCA. Moreover, incubation of ADIC with the enzyme 
PhzD yielded trans-2,3-dihydro-3-hydroxyanthranilic acid (DHHA) and 
incubation of DHHA with PhzA-G showed complete conversion to PCA. Both 
these compounds were thus confirmed as intermediates of phenazine 
biosynthesis. PDC, the previously hypothesised intermediate, was not 
detected in these experiments. To further explore the possibility of PDC 
formation, [11-C13]-labelled PDC was incubated with PhzA-G extract. Less 
than 1% of this labelled PDC was found to be converted into PCA. Moreover, 
the incubation of radiolabelled PDC in the presence of radiolabelled ADIC with 
the same set of enzymes (PhzA-G) yielded no conversion of labelled PDC to 
PCA. Thus, PDC was ruled out as an intermediate of the phenazine 
biosynthesis pathway of P. fluorescens. Instead, the dimerisation of two 
molecules of oxidised DHHA was suggested as a possible mode of phenazine 
scaffold assembly. 
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These observations were collated and presented in the form of a scheme for 
the biosynthesis of PCA from chorismic acid by McDonald and co-workers 
(Fig 1.11), which included the newly identified intermediates and the role of 
enzymes involved. 
1.8. Enzymes of the phenazine biosynthesis operon 
 
While studying the various enzymes involved in the phenazine biosynthesis 
operon of P. fluorescens, McDonald et al. compared the sequences of these 
seven enzymes with proteins of known function. Their results are tabulated in 
table below. 
 
 
 
 
Protein  
 
 
 
Size (amino acids) 
 
 
Similar Enzymes 
 
PhzA 
 
163 
 
PhzB 
 
PhzB 
 
162 
 
PhzA 
 
PhzC 
 
400 
Plant 3 –deoxy-D-arabino-
heptulosonate-7-phosophate 
(DHAP) synthase. 
 
PhzD 
 
207 
 
Bacterial Isochorismate 
 
PhzE 
 
637 
 
Bcterial anthranilate synthase 
 
PhzF 
 
278 
 
Unknown 
 
PhzG 
 
222 
 
Bacterial pyrodoximine 5’-
phosphate oxidase 
 
 
Fig. 1.11 Enzymes similar to those of the phenazine biosynthesis pathway. 
 
There is more than 70% similarity between the genes phzA and B, which were 
found to be important for quantitative synthesis, but not essential for the 
biosynthesis of PCA (74). Both these enzymes however, are conserved in the 
phenazine biosynthesis operons of all Pseudomonas species. The enzymes 
 20
INTRODUCTION 
PhzA-B were thought to act past the formation of DHHA, but no further 
information, either structural or biochemical was available, since these 
enzymes showed no similarity to any enzymes of known function in the NCBI 
database. Of the rest of the enzymes PhzC, D, E, F and G, which are 
essential for PCA production, PhzC, D, E and G were found to have 
counterparts in the bacterial world. PhzC is a 3-deoxy-arabino heptulosonate-
7-phosphate (DAHP) synthase and acts more upstream (prior to formation of 
chorismic acid), ensuring adequate availability of chorismate for phenazine 
biosynthesis. PhzE, which acts after PhzC, shows similarity to bacterial 
anthranilate synthase and catalyses the conversion of chorismate to ADIC. 
This enzyme is followed by PhzD, an Isochorismatase, which catalyses the 
conversion of ADIC to DHHA. This conclusion was recently confirmed by the 
crystal structural analysis of PhzD by Parson et al., (2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.12 Proposed biosynthetic pathway for PCA in Pseudomonas fluorescens 
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Thus, the phenazine biosynthetic gene cluster from P. fluorescens strain 2-79  
(Fig. 1.10) contains 7 genes; of which five (phz C-G) are essential and two 
others (phzA and B) substantially enhance the level of synthesis of 
phenazine-1-carboxylic acid (PCA), the phenazine produced by this organism 
(75). Mc Donald and his coworkers found in their experiments that ADIC is the 
phenazine precursor. 
 
Recently, Blankenfeldt et al., (2004) shed more light on the mode of action of 
the homodimeric enzyme PhzF through structural and biochemical analysis. 
They showed that PhzF acts as an isomerase, converting DHHA to its highly 
reactive ketone form - 1,2,4-trihydro-3-oxo-anthranilic acid. Blankenfeldt and co-
workers also hypothesised that PhzF is an enzyme with dual functions and also 
catalyses the condensation of two molecules of this ketone to form the 
phenazine ring scaffold.  
 
 
Fig. 1.13 Scheme of phenazine biosynthesis modified by Blankenfeldt et al., 2004 
 
The modified scheme proposed by Blankenfeldt et al is depicted in the Fig. 
1.12. The last of the seven enzymes, PhzG, is similar to bacterial 
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pyridoxamine-5-oxidase. It was thought to act in steps past the formation of 
2,3-dihydro-3-oxo anthranilic acid, but its exact role in PCA biosynthesis could 
not be deduced. The functions of the enzymes PhzC, D, E and F were thus 
known or could be accurately surmised (76). However, no such conclusion 
could be drawn for PhzA, B and G.  
As mentioned previously, the end product of core phenazine biosynthesis 
operon, phzABCDEFG, is PCA, which is the only phenazine compound 
synthesised by P. fluorescens. PCA, however is modified to other phenazine 
derivatives in case of Pseudomonas strains like P. aeruginosa, P. 
chlororaphis etc. The genetic basis of generation of phenazine diversity and 
the organization of phenazine biosynthesis operon in other organisms is 
described herewith. 
 
1.8.1. Phenazine modifying enzymes 
 
In Pseudomonas species., the phenazine biosynthetic pathway branches off 
from the shikimic acid pathway, which is also the source for metabolites such 
as the aromatic amino acids, siderophores and quinines (Fig 1.14) (77). 
Genes encoding the phenazine biosynthetic enzymes are arranged in one 
core operon, phzABCDEFG, in most phenazine producing pseudomonads. 
Such an operon exists in the genome of P.aeruginosa in duplicate, and the 
expression of the two copies of the operon is differently regulated. In many 
strains additional genes involved in phenazine decoration, such as phzM, 
phzS, phzO and phzH, are present in single copy and can be located 
proximally to the core operon or elsewhere in the genome; currently, little is 
known about how these genes are regulated (74;76). This project involves the 
study of structure and functional relationship of phenazine modifying enzymes 
encoded by genes phzM and phzS, which are involved in the biosynthesis of 
pyocyanin, a virulence factor for humans. 
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Fig 1.14 Phenazine biosynthesis and its relation to shikimic acid pathway 
(Price-Whelan 2006) 
PhzM is a predicted 36.4-kDa protein similar to enzymes involved in the 
methylation of polyketide antibiotics by Streptomyces spp. Streptomycetes 
produce a variety of bioactive polyketides, many of which contain methyl 
groups introduced via the action of N- and O-methyltransferases. PhzM most 
closely resembles O-methyltransferases from Streptomyces spp. and shares 
with them a putative catalytic domain (residues 137 to 177) that might be 
universal among S-Adenosyl methionine or SAM-dependent 
methyltransferases. The presence of a potential SAM binding site in the N-
terminal part of PhzM (residues 67 to 176) further supports the idea that PhzM 
functions as a methyltransferase (74;78). 
The second putative phenazine-modifying gene, phzS, is located immediately 
downstream of phzA1B1C1D1E1F1G1 and encodes a predicted 43.6-kDa 
protein similar to putative salicylate hydroxylases from S. coelicolor (GenBank 
accession numbers T36193  and CAB95795 ), Bordetella pertussis ( 
AAC46266), Acinetobacter sp. strain ADP1 (AAC27110), and P. aeruginosa 
(AAG06716) and NahW from P. stutzeri AN10 (AAD02157). NahW is of 
particular interest as it is the best-characterized enzyme related to PhzS 
(74;78;79). According to Bosch et al., nahW encodes a flavoprotein 
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monooxygenase with broad substrate specificity that catalyzes conversion of 
salicylic acid and its derivatives to catechol. In a detailed sequence analysis of 
NahW, they identified several conserved motifs present in bacterial salicylate 
hydroxylases. A sequence comparison of PhzS with NahW and other 
salicylate hydroxylases revealed that PhzS contains the consensus NADH 
binding domain (159-DVLVGADGIHSAVR-172), putative N-terminal flavin 
adenine dinucleotide binding site (11-GAGIGG-16), and substrate active site 
(303-GRITLLGDAAHLMYPMGANGA-323).  
 
1.8.2. AdoHcy nucleosidase 
 
 
 
Fig 1.15 Role of AdoHcy nucleosidase 
 
All methyltransferase reactions involve the transfer of the methyl group to a 
specific substrate with the release of one molecule of S-adenosyl-L-
homocysteine (AdoHcy or SAH) (80). In this case PCA is the substrate and 
SAM transfers one methyl group to PCA and itself gets converted to SAH, the 
common product of all SAM dependent methyltransferase reactions (81). 
Under normal physiological conditions, AdoHcy is hydrolyzed to homocysteine 
(Hcy) and adenosine in a reversible reaction catalyzed by SAH hydrolase. 
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However, because the equilibrium constant of SAH hydrolase favours SAH 
synthesis rather than hydrolysis, SAH hydrolysis depends on the efficient 
removal of homocysteine (Hcy) via remethylation to methionine or degradation 
to cysteine. However, it has been found that SAH acts as a competitive 
inhibitor or a potent inhibitor of almost all the SAM dependent 
methyltransferases (82;83). Thus, SAH removal is essential for the continued 
transmethylation activity. This is done by an enzyme termed as adenosyl 
homocysteine (AdoHcy) nucleosidase. This enzyme breaks down AdoHcy to 
adenine and S-ribosylhomocysteine, thereby preventing the inhibition of the 
ethyltransferase activity (84-86).  
ts, we have initiated studies to elucidate their structure–function 
lationships. 
 
m
 
1.8.3. Biosynthesis of pyocyanin 
 
Two steps have been suggested to be involved in the synthesis of pyocyanin 
from phenazine-1-carboxylic acid (PCA), which is the common precursor for 
many different species-specific phenazines. Theoretically, there can be two 
reaction strategies by which PCA can be converted to pyocyanin. In the first 
reaction mechanism, PCA is first acted upon by the enzyme PhzM, an S-
adenosyl methionine (SAM) dependent methyltransferase, and gets converted 
to 5-methylphenazine-1-carboxylic acid betaine by transfer of a methyl group 
to an N atom of the phenazine-ring moiety. This is followed by the action of 
the enzyme PhzS, a FAD-dependent monooxygenase, which involves the 
hydroxylative decarboxylation of 5-methylphenazine-1-carboxylic acid betaine 
to pyocyanin (74). On the other hand in the other reaction strategy leading to 
the biosynthesis of pyocyanin, PCA first gets converted to hydroxyphenazine 
in presence of the enzyme PhzS followed by its methylation to pyocyanin in 
presence of the SAM dependent methyltransferase, PhzM (Fig. 1.11). 
Although the role of pyocyanin in P. aeruginosa infections is well established, 
little is known about the enzymes involved in its biosynthesis. As these 
proteins are potential targets whose inhibition could alleviate the situation of 
affected patien
re
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Fig. 1.16 Proposed biosynthetic pathway for pyocyanin 
 
The synthesis of pyocyanin is affected by carbon and nitrogen sources in 
growth media, but most nutrients support pyocyanin production as long as the 
phosphate ion concentration is low and there is adequate sulfate ion present. 
Synthesis of this pigment also appears to be under the control of iron 
concentration since addition of iron to a medium containing low phosphate 
stimulates the synthesis of pyocyanin and related phenazine pigments by 
other species of bacteria (14). 
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1.9. Regulation of phenazine biosynthesis 
The discovery that bacteria are able to communicate with each other changed 
the general perception of many single, simple organisms inhabiting this world. 
The mode of communication amongst bacteria are signalling molecules, which 
are released into the environment. As well as releasing the signalling 
molecules, bacteria are also able to measure the number (concentration) of 
the molecules within a population. 
The term used for this is quorum sensing which is defined as a phenomenon 
whereby the accumulation of signalling molecules enables a single cell to 
sense the number of bacteria (cell density). Quorum sensing was discovered 
and described over 25 years ago in two luminous marine bacterial species, 
Vibrio fischeri and Vibrio harveyi. Quorum sensing is the regulation of gene 
expression in response to fluctuations in cell-population density. Quorum 
sensing bacteria produce and release chemical signal molecules called 
autoinducers that increase in concentration as a function of cell density. The 
detection of a minimal threshold stimulatory concentration of an autoinducer 
leads to an alteration in gene expression. Different bacterial species use 
different molecules to communicate. Gram-positive and Gram-negative 
bacteria use quorum sensing communication circuits to regulate a diverse 
array of physiological activities. In general, Gram-negative bacteria use 
acylated homoserine lactones as autoinducers, and Gram-positive bacteria 
use processed oligo-peptides to communicate. 
In P. fluorescens, P. aureofaciens and P. chlororaphis, two genes, phzI and 
phzR, located directly upstream to the phenazine biosynthesis operon function 
as regulators of N-acyl-homoserine lactone mediated gene expression of the 
‘phz’ operon. Thus, these two genes link quorum sensing to phenazine 
biosynthesis and act as regulating sub-circuit in these Pseudomonas strains. 
However, this is not the only mode of regulation. As mentioned earlier one of 
the primary factors governing the phenazine production is population density 
and in P.aeruginosa this dependency is effected by three Quorum sensing 
systems of which two quorum-sensing (QS) systems that belong to the LuxR/I 
family have been well characterized.  
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Fig 1.17. Quorum sensing network in Pseudomonas aeruginosa (A.P. Whelan et al 
2006) 
 
In P. aeruginosa, the genes regulating phenazine biosynthesis are not located 
upstream of the core biosynthetic pathway, but elsewhere in the genome. In 
this organism, the expression of phenazine biosynthesis is thought to be 
regulated in a more complex manner. There are two QS systems in P. 
aeruginosa, which have been extensively studied. The las system consists of 
the transcriptional activator protein LasR, the acyl-HSL (homo serine lactone) 
synthase LasI and the acyl homoserine lactone (acyl- HSL) 3O-C12-HSL.The 
rhl system consists of the regulator RhlR, the synthase RhlI and C4-HSL 
(9;87).The las and rhl quorum-sensing circuitries operate in a hierarchical 
cascade responsible for regulating the expression of many virulence 
determinants, secondary metabolites, the type-II secretion machinery, 
stationary phase genes and genes involved in biofilm formation (88;89) 
(Withers et al 2001). Recently, a third signal has been found to participate in 
the P.aeruginosa QS network, the quinolone 2-heptyl-3-hydroxyl-4-quinolone 
that has been named the Pseudomonas quinolone signal (PQS) adds further 
complexity to the regulatory pathway in P. aeruginosa (87;90;91). Till now, 
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PQS has been thought to be the terminal signal in the P.aeruginosa QS 
cascade but recently Dietrich et al in his paper reported that phenazine 
pyocyanin is a terminal signaling molecule in the P.aeruginosa QS network, 
and suggested that phenazines may, in this capacity, control their own cycling 
(92). Pyocyanin is both necessary and sufficient to upregulate the expression 
of a limited set of genes known as the pyocyanin stimulon. As mentioned 
earlier pyocyanin is a good antimicrobial agent and the fact that it can act as 
intercellular signals underscores the possibility that secondary metabolites 
may infact be of primary importance in tuning the cell response to particular 
physiological states (93). This is a good example where secondary 
metabolites prove to have functions that transcend their antibiotic activities 
and enable the coordinated response of microbial communities to changes in 
their environment. Studying the function and structure relationship of enzymes 
PhzM and PhzS can help to understand more about the biosynthesis of 
pyocyanin. 
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As discussed in the earlier section, phenazines are versatile and multi-
functional compounds; but relatively little information is available about the 
biosynthesis of these molecules in nature. A blue, redox active modified 
phenazine compound called pyocyanin is a virulence factor of the 
opportunistic human pathogen P.aeruginosa even in micro molar 
concentrations it is toxic to a wide range of bacterial and mammalian cells. 
Although the role of pyocyanin in P.aeruginosa infections is well established, 
little is known about its biosynthesis and the enzymes involved. 
Understanding the structure of these two enzymes is needed to design 
inhibitors, which could be powerful antibacterial agents and thus, can help us 
tackle the problem of fatal infections caused by phenazine-producing micro-
organisms in immuno-compromised individuals. 
Although it is known that two enzymes are involved in pyocyanin biosynthesis 
but the exact mechanism or the pathway leading to its formation is yet to be 
discovered. The main aim of this project is to better understand reaction 
pathway involving the two enzymes leading to the formation of the virulence 
factor pyocyanin. The specific aims of this work encompasses firstly, the over 
expression, crystallisation and elucidation of the three dimensional structures 
of the enzymes PhzM and PhzS from P.aeruginosa to discover the role played 
by these enzymes. In addition, this project intends to investigate the exact 
mechanism of pyocyanin biosynthesis to establish the identity of the 
substrates and products of the various enzymes as well as the intermediates 
formed during the production of pyocyanin by using some biochemical and 
mass spectroscopic methods. 
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3.1 Materials 
 
3.1.1 Chemicals  
 
Chemicals from the following companies were used: 
 
Amersham-Pharmacia (Freiburg), Baker (Deventer Holland), Fluka (Neu-Ulm), 
GERBU (Gaiberg), Merck (Darmstadt), Pharma-Waldhof (Düsseldorf), Qiagen 
(Hilden), Roche (Mannheim), Roth (Karlsruhe), Serva (Heidelberg), and 
Sigma-Aldrich (Deisenhofen). 
 
3.1.2 Materials 
 
Sterile Filter FP 030/3 0.2 µm (Schleicher and Schuell , Dassel) 
 
Ultrafiltration device VIVASPIN 10, 30 (Vivascience; Lincoln USA) 
 
0.2 µM and 0.45 µM sterile filters (Schleicher and Schuell ) 
 
HiTrap Chelating affinity column HP 5 ml (Amersham Biosciences) 
 
Superdex 75 and 200 (Amershem Pharmacia, Freiburg) 
 
Limbro 24 flat bottom well tissue culture plates (ICN Biomedicals Inc, Ohio) 
 
Garnier TM 96 well flat bottom sitting drop crystallization plates. 
 
3.1.3 Kits 
 
QIAprep Spin Miniprep Kit                                     Qiagen  
 
QIAquick Gel Extraction Kit                                   Qiagen  
 
Perfect 1kb-DNA standard                                     Invitrogen (Karlsruhe) 
 
Wide Range, SDS7 protein marker                       Sigma (Deisenhofen) 
 
1kb ladder for Agarose Gels                                  Gibco 
 
Crystal Screen, 2TM, Index Screen TM                 Hampton Research, 
 
Nextal Classic, PEG ion                                          Nextal 
 
An ÄKTA Prime FPLC machine (Pharmacia) was used throughout for 
chromatography. 
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3.1.4 Microorganisms 
 
E. coli BL21 (DE3) B, F-, hsdSB (rB-, mB-), gal, dcm, ompT, λ (DE3) 
(Novagen) 
 
E. coli BL21 (DE3) F– ompT hsdSB(rB– mB–) gal dcm (DE3) pRARE2 (CmR) 
 
E. coli Rosetta (Novagen) pRARE containing the tRNA genes argU, argW, ileX, 
glyT, leuW, proL, metT, thrT, tyrU, and thru 
 
3.1.5 Plasmid Vectors 
 
pET15b(Novagen). pET15b is a plasmid containing the 6x Histidine sequence 
for use in Nickel chromatography for protein purification. It carries an N-
terminal His-Tag sequence followed by a thrombin site and three cloning sites. 
 
3.1.6 Media and Antibiotics: 
 
Luria-Bertani (LB) medium : 10 g/l Bacto-Tryptone, 10 g/l NaCl, 5 mM NaOH, 
5 g/l yeast extract. 
 
Terrific Broth (TB) medium: 12 g/l Bacto-Tryptone, 24 g/l Bacto-yeast-extract, 
4 g/l glycerol, 17 mM KH2PO4, 72 mM K2HPO4. 
 
GYT medium: 10g/L glucose, 1g/L Yeast extract, 2g/L Tryptose, 1mg FeSO4, 
20g/L Agar. 
 
TSS medium: 10% PEG8000, 5% DMSO, 50mM MgCl2 in LB medium and pH 
adjusted to 6.5. 
 
SeMet Medium: The medium was prepared according to (94). It is a minimal 
medium excluding methionine but containing high concentrations (250 mg/l) of 
the amino acids V, L, I, K, T, F and 50 mg/ml of the other amino acids to aid 
suppression of bacterial methionine biosynthesis. 
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Antibiotics from GERBU (Gaiberg) were used at the concentration 100 mg/l 
for ampicillin and 34 mg/l for chloramphenicol.  
 
3.1.7 Buffers 
 
Method Buffers Used 
 
Nickel Affinity Chromatography 
 
Buffer A: 50mM Na2HPO4, 300mM NaCl 
pH8.0 
Buffer B: Buffer A + 1M Imidazole 
 
Gel Filtration Chromatography 
 
20mM Tris/HCl, 150mM NaCl pH 8.0 
 
 
SDS sample buffer 
50mM Tris, pH = 8.9 
100mM DTT 
2% (w/v) SDS 
0.25% (w/v) Bromophenol blue 
10% Glycerin 
 
 
SDS running buffer 
25mM Tris, pH = 8.3 
192mM Glycine 
 0.1% (w/v) SDS 
 
 
ITC measurements 
 
20mM Tris/HCl, 150mM NaCl pH 8.0 
 
HPLC measurements 
 
Buffer A: Water + 0.1% TFA 
Buffer B: TFA + 0.1% CH3CN  
 
Buffers were prepared in sterile water and degassed before being used. 
 
3.2 COMPETENT CELLS AND TRANSFORMATION 
 
Sterile media and solutions were chilled prior to use unless otherwise 
indicated.  
Competent cells for protein expression (Rosetta pLysS) or plasmid 
amplification (XL1-Blue) were prepared as follows: 
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Electrocompetent cells were prepared by inoculating a single colony 
Escherichia coli cells in 100 ml Luria Broth (LB) medium and grown overnight 
at 37ºC under continuous shaking. The next day, 5 ml preculture were diluted 
with 500 ml LB medium and grown further to optical density OD600 = 0.6. The 
cells were harvested by centrifugation at 3000xg for 15 minutes. The pellet 
was washed with 500 ml sterile H2O at 4ºC twice. The pellet was then 
resuspended in 10 ml 10% glycerol (4ºC) and recentrifuged. The resulting cell 
pellet was finally resuspended in approximately 2.5 ml GYT media (4ºC) and 
aliquoted into 75 µl portions flash frozen in liquid nitrogen and stored at -80ºC 
till further use.  
 
Heat shock competent cells were prepared by growing the cells in 30 
ml of LB medium at 37ºC with continuous shaking. Next day the overnight 
culture was then inoculated with 100 ml of LB starting with an OD600 of 0.2-
0.3. The cells were grown at 37ºC to an OD600 of 0.7-0.8. The growth was 
stopped by putting the culture on ice. The cells were then centrifuged in 50 ml 
falcon tubes at 2000 rpm for 15 mins at 4ºC. The resulting cell pellet was 
finally resuspended in approximately 2.5 ml TSS media (4ºC) and aliquoted 
into 100 µl portions flash frozen in liquid nitrogen and stored at -80ºC till 
further use. 
 
3.2.1 Transformation by heat shock 
 
100 µl of the competent cell were incubated with approximately 1 ng of DNA on 
ice for 30 mins. After this the cells were subjected to heat shock treatment by 
placing them at 42ºC for 90 mins. This opens up the cell walls for the 
introduction of the plasmid DNA. This is followed by transferring the cells on ice 
for 5mins. The cells are then transferred to 1ml of LB medium and allowed to 
incubate at 37ºC while shaking. The cells are centrifuged carefully discarding 
900 µl supernatant; the bacteria were resuspended and plated on an agar 
selection medium containing the appropriate antibiotic. 
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3.2.2 Transformation by electroporation 
 
50 µl of the competent cells were incubated with approximately 100 ng of 
DNA in a dry and previously chilled electrocompetent cuvette and then 
transformed using a transformation apparatus controlled at a voltage of 2.5 
kV. The cells were then transferred to 1 ml of LB medium and were grown at 
37ºC for 1 hr. The cells were then centrifuged carefully discarding 900 µl 
supernatant; the bacteria were resuspended and plated on an agar selection 
medium containing the appropriate antibiotic.  
 
3.3 PROTEIN OVEREXPRESSION AND PURIFICATION 
 
3.3.1 Protein Expression 
 
The proteins were expressed in E.coli strain Rosetta pLysS (DE3) (Novagen). 
An overnight culture from a single colony was grown and diluted the next 
morning with fresh medium suspended with 100 mg/l ampicillin and 34 mg/l 
chloramphenicol. The cells were grown at 37ºC with vigorous shaking until an 
OD600 = 0.6. Protein expression was induced using 1mM isopropyl-ß-D-
thiogalactoside (IPTG) for 3 hours at 37ºC. The cells were harvested by 
centrifugation for 15 minutes at 6000×g. When not immediately used for 
protein purification, the pellets were flash frozen and stored at -80ºC. 
 
3.3.2 Protein Purification 
 
The cell pellet was resuspended in Buffer A containing 1 mM protease 
inhibitor PMSF (Phenylmethylsulfonyl fluoride, protease inhibitor). The cells 
were lysed in a microfluidizer (model 110S, Microfluidics Cooperation, USA). 
The lysate was then ultracentrifuged at 150000×g (Beckman ultracentrifuge 
model Optima L-70K, rotor Ti45) for 45 minutes and the resulting supernatant 
was filtered through a 0.2 µm filter. The supernatant was loaded onto a nickel-
chelation column (Hi-Trap Chelating, Qiagen), equilibrated in Buffer A on an 
Äkta Prime FPLC system (Pharmacia). The column was washed with 6-8 
column volumes of Buffer A containing 2% Buffer B after which the bound 
protein was eluted in an imidazole gradient of 2 to 100% Buffer B. The 
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fractions containing the desired protein were identified by SDS-PAGE and 
pooled. 
 
3.3.3 SDS-PAGE 
 
Separation of proteins of different molecular weight was performed according 
to Laemmli (Nature 227, 1970) using denaturing 15% SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) (95;96). The running gel was composed of 15% 
acrylamide, 0.4% bisacrylamide, 0.1% (w/v) SDS and 375 mM Tris, pH 8.8. 
The polymerisation of the gel material was initiated by adding 14 µM/µl 
N,N,N,N-Tetramethyl-Ethylenediamine (TEMED) and 0.5 mg/ml ammonium 
persulphate (APS). The gel was casted by pouring it into the casting chamber 
and covering it with isopropanol/water 1:1. After polymerisation, the 
isopropanol/water mixture was replaced by the stacking gel composed of 5% 
acrylamide, 0.13% bisacrylamide, 0.1% (w/v) SDS, 125 mM Tris, pH 6.8, 14 
µM/µl TEMED and 0.5% mg/ml APS. Prior to application on the gel, the 
protein samples were denatured by incubation for 2 mins at 95ºC in SDS 
sample buffer. The protein molecular weight marker (LMW-Standard, 
Amersham Biosciences) was composed of protein phosphorlylase b (97 kDa), 
albumin (67 kDa), ovalbumin (43 kDa), carboanhydrase (30 kDa), trypsin 
inhibitor (20.1 kDa) and lysozyme (14.4 kDa). The electrophoresis took place 
at 60 mA in SDS running buffer. The gels were stained with a Commasie Blue 
solution and then destained with destaining solution containing 5% Ethanol 
and 10% Acetic Acid to display the protein bands. 
 
3.3.4 Size exclusion chromatography 
 
The fractions collected from the affinity chromatography column were 
collected and dialysed overnight at 4ºC against dialysis buffer to remove 
imidazole. The dialysed protein sample was then concentrated and subjected 
to the final step of purification involving gel filtration. This purification was 
carried out in a Superdex G75/200 HR 26/60 column (Amersham Pharmacia 
Biotech), which was pre-equilibrated with the gel filtration buffer. The 
concentrated protein was injected and FPLC was then carried out at a flow-
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rate of 2 ml/min and 4 ml fractions were collected. The protein fractions were 
analyzed with SDS PAGE. 
 
3.3.5 Determination of protein concentration  
 
Protein concentration was determined according to Bradford (1976) using the 
Biorad protein assay solution. This solution was calibrated prior to use by 
Bovine Serum Albumin (BSA). 
 
3.3.6 Final concentration and storage of protein 
 
Finally, the purified protein was concentrated using an Amicon chamber with 
the respective cut off membrane. The concentrated protein was then aliquoted 
to 30-50 µl fractions, flash frozen and stored at -80ºC. 
 
3.3.7 Seleno-L-methionine labelled protein 
 
The preparation of selenomethionine- labelled proteins has become a 
fundamental part of many crystallographic studies. For the purpose of 
structural solution using SAD (Single-wavelength Anomalous Diffraction)/MAD 
(Multi-wavelength Anomalous Diffraction), inhibition of methionine 
biosynthesis in synthetic media (Doublie, 1978) was undertaken to incorporate 
seleno-L-methionine in the protein (97). Proteins labelled with 
selenomethionine are useful for determining structures of proteins by X-ray 
crystallography. E.coli Rosetta pLysS cells bearing the pET-15b plasmid 
incorporating 6xHis-tagged protein were grown overnight in LB media 
supplemented with ampicillin and chloramphenicol. The cells were then 
pelleted and resuspended in SeMet media containing 50 µg/ml ampicillin and 
17 µg/ml chloramphenicol. This culture was grown at 37ºC to OD600 of 0.8 and 
the amino acids lysine, phenylalanine and threonine (100 mg/L) and 
isoleucine, leucine and valine (50 mg/L) were added. The culture was then 
supplemented with 60 mg/L seleno-L-methionine and allowed to cool to 20ºC 
before induction with 1mM IPTG and incubated at 20ºC overnight, with 
continuous shaking. The protein purification protocol remained identical to that 
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for the native protein. Incorporation of selenium was confirmed by MALDI-TOF 
mass spectrometry. 
 
3.3.8 High Pressure Liquid Chromatography (HPLC) 
 
The HPLC separations were run under the following conditions: A gilent 
1100HPLC equipped with degasser, auto-sampler, two binary pumps, diode 
array detector connected on-line to a Finnigan LCQ Advantage mass 
spectrometer; C18 Atlantis column; flow rate 1 ml/min; solvent A: 0.1 % formic 
acid in water, solvent B 0.1 % formic acid in acetonitrile; gradient: 0-1 min 0 % 
B, 1-15 min 0-50 % B 15-25 min 50-100 % B, re-equilibration of the column in 
5 min; positive ion mode detection. 
 
3.4 Methods for protein analysis 
 
3.4.1 Isothermal Titration Calorimetry (ITC) 
Isothermal Titration Calorimetry (ITC) is a biophysical technique used to 
Ligand injecting syringe 
Reference cell             Sample cell 
Stirrer 
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Fig 2.1 Schematic of an ITC instrument 
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determine the thermodynamic parameters of interactions between ligands 
such as proteins and peptides, or proteins and other ligands (e.g. lipid heads 
groups). In other words Isothermal Titration Calorimetry is a thermodynamic 
technique for monitoring any chemical reaction initiated by the addition of a 
binding component, and has become the method of choice for characterizing 
biomolecular interactions. Measurement of this heat allows accurate 
determination of binding constants (KB), reaction stoichiometry (n), enthalpy 
(ΔH) and entropy (ΔS), thereby providing a complete thermodynamic profile of 
the molecular interaction in a single experiment. 
The entropy change (∆S) of binding is calculated from ∆H and KB  
 
ΔG  =  -RTln KB  = ΔH - T ΔS 
 
Where, G is Gibbs free energy, R is gas constant, T is absolute temperature. 
 
An ITC instrument consists of two identical cells composed of a highly efficient 
thermal conducting material such as Hastelloy alloy or gold, surrounded by an 
adiabatic jacket (Figure 2.1) The jacket is usually cooled by a circulating water 
bath. Sensitive thermopile/thermocouple circuits detect temperature 
differences between the two cells and between the cells and the jacket. 
Heaters located on both cells and the jackets are activated when necessary to 
maintain identical temperatures between all components. 
 
In an ITC experiment, the macromolecule solution is placed in the sample cell. 
The reference cell contains buffer or water minus the macromolecule. Prior to 
the injection of the titrant, a constant power (1 mW) is applied to the reference 
cell. This signal directs the feedback circuit to activate the heater located on 
the sample cell. This represents the baseline signal. The direct observable 
measured in an ITC experiment is the time-dependent input of power required 
to maintain equal temperatures in the sample and reference cell. During the 
injection of the titrant into the sample cell, the two materials (macromolecule 
and ligand) interact and heat is taken up or evolved depending on whether the 
macromolecular association reaction is endothermic or exothermic. For an 
exothermic reaction, the temperature in the sample cell will increase, and the 
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feedback power will be deactivated to maintain equal temperatures between 
the two cells. For endothermic reactions the reverse will occur, meaning the 
feedback circuit will increase power to the sample cell to maintain the 
temperature. As the macromolecule in the cell becomes saturated with ligand, 
the heat signal diminishes until only background heat of dilution is observed. 
 
 
Syringe 
Sample cell 
 
Fig 2.2 MicroCal Isothermal Titration Calorimeter 
 
3.4.2 Mass Spectrometry 
 
Mass spectrometry is an analytical technique used for measuring the 
Molecular Weight (Mw) of samples. Mass spectrometers use the difference in 
mass-to-charge ratio (m/z) of ionized atoms or molecules to separate them 
from each other. Mass spectrometry is therefore useful for quantitation of 
atoms or molecules and also for determining chemical and structural 
information about molecules. Molecules have distinctive fragmentation 
patterns that provide structural information to identify structural components. 
Mass spectrometers can be divided into three fundamental parts, namely the 
ionisation source, the analyser, and the detector. 
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3.4.2.1 HPLC-APCI-MS 
 
An important enhancement to the mass resolving and determining capacity of 
mass spectrometry is the combination of mass spectrometry with analysis 
techniques that resolve mixtures of compounds in a sample based on other 
characteristics before introduction into the mass spectrometer. One effective 
method or way to determine small amount of substance is to combine or 
couple these two different analytical methods. Mass Spectrometry (MS) 
combined with the separation power of chromatography has revolutionised the 
way we do chemical analysis today. Here we have coupled High Performance 
Liquid Chromatography (HPLC) with Mass Spectrometry. High performance 
liquid chromatography mass spectrometry is an extremely versatile 
instrumental technique whose roots lie in the application of more traditional 
liquid chromatography to theories and instrumentation that were originally 
developed for gas chromatography (GC). As the name suggests the 
instrumentation comprises a high performance liquid chromatograph (HPLC) 
attached, via a suitable interface, to a mass spectrometer (MS) (Figure 2.3). 
The primary advantage HPLC/MS has over GC/MS is that it is capable of 
analysing a much wider range of components. Compounds that are thermally 
labile exhibit high polarity or have a high molecular mass can all be analysed 
using HPLC/MS, even proteins are routinely analysed using HPLC/MS. 
Solutions derived from samples of interest are injected onto an HPLC column 
that comprises a narrow stainless steel tube (usually 150 mm length and 2 
mm internal diameter, or smaller) packed with fine, chemically modified silica 
particles. Compounds are separated on the basis of their relative interaction 
with the chemical coating of these particles (stationary phase) and the solvent 
eluting through the column (mobile phase). Components eluting from the 
chromatographic column are then introduced to the mass spectrometer via a 
specialised interface. The two most common interfaces used for HPLC/MS 
are the electrospray ionisation and the atmospheric pressure chemical 
ionisation (APCI) interfaces. In this case we have used the later for the 
analysis. 
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 Fig 2.3 A HPLC-APCI mass spectrometer 
 
3.4.2.1.1 HPLC 
 
High-performance liquid chromatography or High-pressure liquid 
chromatography is an analytical chromatographic technique used to separate 
components of a mixture by using a variety of chemical interactions between 
the substance being analyzed (analyte) and the chromatography column. The 
basic operating principle of HPLC is to force the analyte through a column of 
the stationary phase (usually a tube packed with small spherical particles with 
a certain surface chemistry) by pumping a liquid (mobile phase) at high 
pressure through the column. The sample to be analyzed is introduced in 
small volume to the stream of mobile phase and is retarded by specific 
chemical or physical interactions with the stationary phase as it traverses the 
length of the column. The amount of retardation depends on the nature of the 
analyte, stationary phase and mobile phase composition. The time at which a 
specific analyte elutes (comes out of the end of the column) is called the 
retention time and is considered a reasonably unique identifying characteristic 
of a given analyte. 
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3.4.2.1.2 APCI or Atmospheric Pressure Chemical Ionisation 
 
Atmospheric Pressure Chemical Ionisation or APCI produces ions using a 
reagent gas generated from solvent vapour. The solvents are solvent A 
containing 0.1% formic acid in water and solvent B containing 0.1% formic 
acid in acetonitrile and the flow rate used was 1 ml/min. Liquid spray is 
produced by passing co-axial nebuliser gas (nitrogen) over the tip of a fused 
silica capillary, housed within the probe. The solvent spray is vaporised by a 
heater coil at 400°C. Once formed, the vapour is ionised by a strong electric 
field emanating from a corona pin held at 3 kV (Figure 2.4). 
 
Fig 2.4 Atmospheric Pressure Chemical Ionisation 
 
Atmospheric pressure chemical ionisation (APCI) is an analogous ionisation 
method to chemical ionisation (CI) and has its primary applications in the 
areas of ionisation of low mass compounds (APCI is not suitable for the 
analysis of thermally labile compounds). In ESI, ionisation is brought about 
through the potential difference between the spray needle and the source-
sampling cone along with rapid but gentle desolvation. In APCI, the analyte 
solution is introduced into a pneumatic nebulizer and desolvated in a heated 
quartz tube before interacting with the corona discharge creating ions. The 
corona discharge replaces the electron filament in CI - the atmospheric 
pressure would quickly "burn out" any filaments - and produces primary N2°+ 
and N4°+ by electron ionisation. These primary ions collide with the vaporized 
solvent molecules to form secondary reactant gas ions. These reactant gas 
ions then undergo repeated collisions with the analyte resulting in the 
formation of analyte ions. The high frequency of collisions results in a high 
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ionisation efficiency and thermalisation of the analyte ions. This results in 
spectra of predominantly molecular species and adduct ions with very little 
fragmentation. Once the ions are formed, they enter the pumping and 
focussing stage in much the same as ESI (Figure 2.5). 
 
 
 
 
 
 
 
 
 
Fig 2.5 A schematic of the components of an APCI source 
(http://www.bris.ac.uk/nerclsmsf/techniques/hplcms.html) 
 
3.4.2.1.3 Reaction Mixture for HPLC-APCI-MS 
 
To monitor the reaction catalysed by enzymes PhzM and PhzS and to detect 
the intermediates that were formed, various combinations of the reaction 
mixtures (as mentioned in the table below) were prepared. Samples were 
prepared in 50 mM Tris Buffer (pH 7.5) containing 10µM of the marker 
molecule caffeine. The inclusion of caffeine allowed a comparison of the 
various spectra obtained during the course of this work. Buffers used for the 
whole reaction were Buffer A containing H2O and 0.1% HCOOH and Buffer B 
containing ACN and 0.1% HCOOH. In a glass vial (Agilent Technologies) 100 
µM of the substrate in Tris buffered (50 mM; pH 7.5) solution was prepared 
and 1.0 µl of this solution injected directly into the spectrometer and analysed 
to get a time zero (t=0; blank reading). After this, the enzymes along with the 
respective cofactors were added to initiate the reaction. A spectrum was 
recorded every 10 mins for a period of approximately 150-200 mins. 
Manufacturer’s software ‘Xcalibur’ (Voyager Mass Spectroscopy Systems) 
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was used for data analysis and Excel (Microsoft) for representation of the 
data. 
 
Substrate (100 µM) Cosubstrate 
(1mM) 
Enzyme (10 µM) Reducing agent 
PCA SAM PhzM TCEP 
1-oh-phz NADH PhzS DTT 
 NADPH AdoHcy Na2S2O4 (1mM, 5mM)
 
3.4.3 UV-VIS SPECTROSCOPY 
 
UV-Visible spectroscopy is the measurement of the wavelength and intensity 
of absorption of near-ultraviolet and visible light by a sample. The absorption 
of visible light is what makes things coloured. For example, the oxidized form 
of pyocyanin appears blue because the light at the red end of the spectrum is 
absorbed. This leaves the blue light to be reflected to the observer’s eye. This 
principle is used to determine the effect in the quantity of pyocyanin formed in 
the presence or absence of AdoHcy nucleosidase. 
 
The basic parts of a spectrophotometer are a light source (often an 
incandescent bulb for the visible wavelengths, or a deuterium arc lamp in the 
ultraviolet), a holder for the sample, a diffraction grating or monochromator to 
separate the different wavelengths of light, and a detector (Figure 2.6). The 
detector is typically a photodiode or a CCD. Photodiodes are used with 
monochromators, which filter the light so that only light of a single wavelength 
reaches the detector. Diffraction gratings are used with CCDs, which collects 
light of different wavelengths on different pixels. 
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Fig 2.6 A schematic diagram of a single beam UV-Visible Spectrometer 
 
Samples are used in solution and are placed in a small silica cell. Two lamps 
are used. A hydrogen or deuterium lamp for the ultraviolet region and a 
tungsten/halogen lamp for the visible region. In this case first 1 ml of the 
reference solution was prepared containing 1 mM of PCA, SAM, NADH in 
Tris/HCl-Buffer in a cuvette. Spectra were measured within the wavelength 
range of 210 to 800 nm. After this 10 µM of the enzymes PhzM and PhzS 
were introduced and mixed well in the cuvette. Spectra were measured after 
an interval of 5 mins for 25 mins within the wavelength range of 210-800 nm. 
Similarly another sample mixture was prepared containing all the components 
mentioned earlier and 10 µM of AdoHcy nucleosidase and spectra were 
measured. This showed how the presence of AdoHcy nucleosidase in the 
reaction can effect the quantity of pyocyanin formed. 
 
3.5 Crystallographic methods 
 
Proteins, like many molecules, can be prompted to form crystals when placed 
in the appropriate conditions. Determining the structure of a protein by X-ray 
crystallography entails growing high-quality crystals of the purified protein, 
measuring the directions and intensities of X-ray beams diffracted from the 
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crystals, and using a computer to stimulate the effects of an objective lens and 
thus produce an image of the crystal’s contents. Finally that image must be 
interpreted, which entails displaying it by computer graphics and building a 
molecular model that is consistent with the image. Thus, the goal of 
crystallization is usually to produce a well-ordered crystal that is lacking in 
contaminants and large enough to provide a diffraction pattern when hit with 
x-ray. This diffraction pattern can then be analyzed to discern the protein’s 
three-dimensional structure. 
 
Crystals of an inorganic substance can often be grown by making a hot 
saturated solution of the substance and then slowly cooling it. Polar 
compounds can sometimes be crystallized by similar procedures or by slow 
precipitation from aqueous solutions by addition of organic solvents. However 
in case of proteins these conditions won’t apply as the proteins are denatured 
by heating or exposure to organic solvents. In order to crystallize a protein, 
the purified protein undergoes slow precipitation from an aqueous solution. As 
a result, individual protein molecules align themselves in a repeating series of 
"unit cells" by adopting a consistent orientation. The crystalline “lattice” that 
forms is held together by noncovalent interactions (98;99). Protein 
crystallization is inherently difficult because of the fragile nature of protein 
crystals. In addition to overcoming the inherent fragility of protein crystals, the 
successful production of x-ray worthy crystals is dependent upon a number of 
environmental factors because so much variation exists among proteins, with 
each individual requiring unique conditions for successful crystallization. 
Some factors that require consideration are: 
 
• Purity of the protein: In order for sufficient homogeneity, the protein 
should usually be at least 97% pure. 
• Concentration of the protein and the precipitant 
• pH conditions are also very important, as different pH’s can result in 
different packing orientations. Buffers, such as Tris-HCl, are often 
necessary for the maintenance of a particular pH (Branden and Doze, 
1999). 
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Apart from the conditions mentioned above there are some subtle conditions 
like cleanliness, vibration and sound, convection, source and age of protein, 
and the presence of ligands that also influence the formation of 
macromolecular crystals A protein will stay in solution only up to a certain 
concentration. Once this limiting concentration is reached, the solution will no 
longer remain homogeneous, but a new state or phase will appear. This 
phenomenon forms the basis of all protein crystallization experiments. By 
changing the solution conditions, the crystallographer tries to exceed the 
solubility limit of the protein so as to produce crystals. However, merely 
changing the concentration doesn’t not guarantee the formation of protein 
crystals in majority of the cases. Many things can happen instead of getting 
crystals (a) nothing happens i.e., the protein solution remains homogenous, 
(b) a new phase appears but its not a crystal instead an aggregate or a liquid, 
(c) the crystals appear but unsuitable for structural determination because of 
poor diffraction pattern obtained. 
 
An important tool in this work is the phase diagram (Fig 2.7). A complete 
phase diagram shows the state of a material as a function of all of the relevant 
variables of the system. For a protein solution, these variables are the 
concentration of the protein, the temperature and the characteristics of the 
solvent (e.g., pH, ionic strength and the concentration and identity of the 
buffer and any additives) (Neer Asheri ,Methods , Mar 2004). 
 
In principle, supersaturation is the key for the crystallization of the proteins. In 
practice, crystals hardly ever form unless the concentration exceeds the 
solubility by a factor of at least three. The large supersaturation is required to 
overcome the activation energy barrier, which exists when forming the crystal. 
This barrier represents the free energy required to create the small 
microscopic cluster of proteins—known as a nucleus—from which the crystal 
will eventually grow. 
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Fig 2.7 Phase Diagram showing zones for crystal nucleation, growth, precipitation. 
 
Since there is an energy barrier, nucleation (the process of forming a nucleus) 
takes time. If the supersaturation is too small, the nucleation rate will be so 
slow that no crystals form in any reasonable amount of time. The 
corresponding area of the phase diagram is known as the “metastable zone”. 
In the “labile” or “crystallization” zone, the supersaturation is large enough that 
spontaneous nucleation is observable. If the supersaturation is too large, then 
disordered structures, such as aggregates or precipitates, may form. The 
“precipitation zone” is unfavorable for crystal formation, because the 
aggregate and precipitates form faster than the crystals. The precipitation 
zone is where the excess of protein molecules immediately separates from 
the solution to form amorphous aggregates. To grow well-ordered crystals of 
large size, the optimal conditions would have to begin with the formation of a 
preferably single nucleus in the nucleation zone just beyond the metastable 
zone. As the crystals grow, the solution would return to the metastable region 
and no more nuclei could occur. The remaining nuclei would grow, at a 
decreasing rate that would help to avoid defect formation until equilibrium is 
reached. The three zones are illustrated schematically in the Fig 2.7. Since 
these zones are related to kinetic phenomena, the boundaries between the 
zones are not well defined. 
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3.5.1 Crystallisation by Vapour-Diffusion 
 
In the most common methods of growing protein crystals, purified protein is 
dissolved in an aqueous buffer containing a precipitant such as ammonium 
sulfate or polyethylene glycol at a concentration just below that is necessary 
to precipitate the protein. 
By far the vapour diffusion method is the most common and popular technique 
for crystallising proteins. It was first used for the crystallisation of tRNA. In this 
technique a drop containing protein, stabilizing buffers, precipitants and 
crystallization aids is allowed to equilibrate in a closed system with a much 
larger reservoir. The reservoir usually contains the same chemicals minus the 
protein but at an over all higher concentration so that water preferentially 
evaporates from the drop. If conditions are right this will produce a gradual 
increase in protein and precipitant concentrations so that a few crystals may 
form. Usually there are two different techniques in which the vapour diffusion 
method is carried out; ‘’the sitting drop "and "the hanging drop’’ method (Fig 
2.8 (a) and (b)). 
 
 
 
 
 
Fig 2.8 (b). The hanging drop method 
 
 
 
 
 
 
Fig 2.8 (a). The sitting drop method 
 
For the crystallising purpose in our case the concentrated aliquots of native 
proteins (PhzM and PhzS) were thawed and subjected to screening using 
Crystal Screen and Crystal Screen 2 of Hampton Research (100-102). The 
protein concentration was screened at 10 and 15 mg/ml for PhzS and 5, 10 
and 15 mg/ml for PhzM by dilution of the protein stock with gel filtration buffer. 
The hanging drop vapour diffusion method with drops consisting of 1.2 µl 
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protein and 1.2 µl precipitant solution was used throughout. All crystallization 
trials were carried out at 20 °C. The conditions were checked for the 
appearance of crystals periodically. Conditions that produced micro crystals 
were optimized with respect to precipitant concentration and pH to reduce the 
amount of nucleation and increase the size and appearance of crystals 
obtained. 
 
3.5.2 Selecting a cryoprotectant 
 
After optimised crystals are obtained they need to be exposed to X-rays for 
collecting diffraction data and to prevent them from being destroyed by 
radiation they are flash cooled in liquid nitrogen (yields the highest cool-down 
rate). Flash-cooled crystals are much less prone to radiation damage than 
their room-temperature counterparts, allowing data to be accumulated over 
extended periods of time. In theory lowering the temperature should increase 
the molecular order in the crystal and improve diffraction. In practice, 
however, early attempts to freeze crystals resulted in damage due to 
formation of ice crystals. In recent years techniques were developed for flash 
freezing crystals in presence of agents like sugar or glycerol, which prevent 
ice formation. These ice-preventing agents are called cryoprotectants. In all 
cases of ice formation on cooling to cryogenic temperatures the process starts 
in a layer of liquid on the surface of the crystal. It is therefore necessary to 
remove or modify this layer with a cryoprotectant. Typically the cryoprotectant 
is added to a portion of mother liquor, usually in the range 10-25% by volume. 
Because the action is at the surface of the crystal, it is normally not necessary 
to soak the crystal for any length of time. A few seconds (<10 s) of rinsing will 
often suffice. 
 
In order to check for a suitable cryo first the solution to be used as the 
cryoprotectant is flash frozen in liquid nitrogen. Then the cryo solution is 
checked for ice formation either visually or with X-ray diffraction. Upon 
cooling, a transparent drop and x-ray diffraction pattern free of powder 
diffraction rings or “ice rings,” indicates success. The appearance of a cloudy 
drop or “ice rings” indicates an inappropriate cryoprotectant concentration or 
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cryoprotectant. Some precipitants for example polyethylene glycol (PEG), act 
as cryoprotectant and often just increasing their concentration in the mother 
liquor is sufficient to use the mother liquor as the cryo and in some cases 
additional compounds need to be added to the mother liquor eg. glycerol or 
sugar. 
 
In addition to better diffraction, other benefits of using a cryoprotectant include 
reduction of radiation damage to the crystal and hence possibility of collecting 
more data form a single crystal; reduction of X-ray scattering from water 
(resulting in cleaner backgrounds in diffraction patterns) because the amount 
of water surrounding the crystal Is far less than that in a droplet of mother 
liquor; and the possibility of safe storage, transport and reuse of crystals. 
 
3.5.3 Data collection and processing 
 
All cryoprotected crystals were initially tested at home source - a copper 
rotating anode with Osmic mirrors (λ = 1.5419 Å, 50 kV, 100 mA, 0.1 mm 
collimator) at 100 K. Final datasets were then obtained at the synchrotron 
sources mainly, the ESRF at Grenoble, France and the SLS at Basel, 
Switzerland. 
 
It is important to collect as complete data as possible, i.e., to record nearly all 
reflections up to the resolution limit (which is often due to the crystal quality). 
In order to understand which reflections are collected, one can look at the 
Ewald Sphere, which is constructed in reciprocal space. When a lattice point 
crosses the Ewald sphere, a reflection occurs in the direction determined by 
the centre of the sphere and the point of intersection. 
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Fig 2.9. The Ewald Sphere 
 
In order to collect a diffraction data, a monochromatic (single wavelength) 
source of X-ray is needed or desirable because the diameter of the sphere of 
reflection is 1/ λ, and a source producing two distinct wavelengths of radiation 
gives two spheres of reflection and two interspersed sets of reflections making 
indexing difficult or impossible because of overlapping reflections. 
 
3.5.3.1 Data Collection 
 
X-ray data processing is a key stage for protein crystallography. The final 
quality of X-ray data is related with the data processing procedure, which 
includes integration of the crystallographic data and scaling. Absolute 
requirement for the successful analysis of a protein structure is a well-ordered 
protein crystal, grown from protein of highest purity. During the central 
experiment of data collection a protein crystal is positioned into an X-ray 
beam. Through the combination of scattering and interference a diffraction 
pattern is generated, which is recorded in an X-ray sensitive device. The 
diffraction is described by the following term  
Bragg’s Law        n λ   =   2 d sin θ 
 
Where, d = distance between two parallel reflecting planes of the crystal, 
             λ = the wavelength and 
             n = an integral number 
MATERIALS AND METHODS 
 
 57
In order to collect X-ray diffraction data the crystals were rotated around an 
axis perpendicular to the beam in steps of ∆φ = 0.5 – 1.0 degrees over a 
range of typically 90° – 180°. Per rotation step one diffraction image was 
recorded and all reflections from all diffraction images ("frames") together 
constitute a complete data set. This raw data obtained is subsequently 
processed by a series of different steps mainly Indexing, Integrating and 
Scaling (103). 
 
3.5.3.2 Data Processing 
Indexing  
 
The positions of the diffraction maxima on the X-ray detector are directly related 
to shape and size of the crystal unit cell. The unit cell of the crystal and the 
diffraction pattern are related by a reciprocal relationship. Each reflection can 
be assigned three coordinates or indices in the imaginary three-dimensional 
space of diffraction pattern. This space where the reflections live, is called the 
reciprocal space due to a reciprocal relation between diffraction pattern and 
crystal lattice. Usually set of integral indices h, k, and l, the so called Miller 
indices are used to designate the position of an individual reflection in the 
reciprocal space of the diffraction pattern. 
 
Integration  
 
Data collection results in a list of images, each representing a wedge of the 
rotation of the crystal in the beam. The images are distorted sections of 
reciprocal space. Data integration has to reconstitute the original, undistorted 
lattice in 3 dimensions. 
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Find reflection
Deskew spot shape
Determine spot shape (height,borders) 
Add pixel values (get intensities)
Remove background contribiution
Fig 2.10 The data integration flow chart 
 
Scaling  
 
“Scaling” refers to putting single diffraction images/frames to the same scale 
such that “partially” recorded reflections (extending over several frames) can  
be summed up and symmetry-equivalent reflections can be “merged”. The 
(experimental) differences in intensities necessitates the scaling of the data: 
All reflections must be put on a common scale. To do so, one takes symmetry 
related reflections into account: Reflections that are related by one of the 
symmetry operators of the crystal’s space group must have equal intensities. 
 
Data processing was carried out using the program XDS (104), which 
incorporates all of the above-mentioned steps. Other parameters affecting 
data processing like mosaicity, Matthew’s coefficient etc., were also 
calculated. 
 
The regular repetition of the unit cells is normally interrupted by lattice defects. 
The diffraction pattern of a crystal is infact the sum of diffraction patterns 
originating from mosaic blocks with slightly different orientations. Mosaicity 
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values were checked to ensure that the lattice defects are moderate (between 
0.2°- 0.5°). 
Typically, 30-80% of the unit cell volume is occupied by solvent. Based on the 
volume of asymmetric unit (determined by x-ray measurements) and 
molecular weight of the protein one can estimate the number of protein 
molecules present in a unit cell by calculating Matthew’s coefficient (VM) via 
the equation: 
 
 
                                                                                   
 
Where, 
                      V = Volume of the asymmetric unit (Å3) . 
                   Mw = Molecular weight of the protein (k Da). 
                      Z = Number of molecules in the asymmetric unit. 
 
The average Matthew coefficient for a protein crystal is 2.5 Å3/Da, which 
corresponds to a unit cell solvent content of 50% (Matthews, 1968). 
 
3.5.4 Determination of Phases 
 
The interaction of X-rays with electrons in a crystal gives rise to a diffraction 
pattern. Because of the physics of diffraction, this diffraction pattern is the 
Fourier transform of the electron density distribution. Fourier transforms can, 
in principle, be reversed so it is possible to reconstruct the distribution of 
electrons (hence of atoms) in the crystal. Unfortunately, to do this we need not 
only the amplitudes of the diffracted waves, which are obtained from the 
intensities of the diffraction spots, but also their relative phase shifts, which 
cannot be measured directly. This problem is known as the phase problem of 
crystallography. The only relationship is via the molecular structure or electron 
density. Therefore if there is some prior knowledge of the structure or electron 
density, this can lead to values of phases. One of the major efforts of 
macromolecular crystallography lies in determining good phases. The 
following are the most frequently used techniques: 
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 Direct methods (small molecules and high resolution only) 
 Molecular Replacement (MR) 
 Isomorphous Replacement 
 Anomalous Scattering (MAD, SAD) 
 
For a normal diffraction experiment, Friedel’s law is valid, which states that the 
intensities of the reflection (h, k, l) and (−h,−k,−l) are equal and that the 
phases of the underlying structure factor have opposite signs, _(h, k, l) 
−_(−h,−k,−l). One method of obtaining phases is by using heavy atom 
derivative by taking into advantage the heavy atom’s capacity to absorb X-
rays of specified wavelength. As a result of this absorption Friedel’s law does 
not hold, and the reflections (h, k, l) and the inverse (–h –k –l) are not equal in 
intensity. This inequality of symmetry-related reflections is called anomalous 
scattering or anomalous dispersion. The single wavelength anomalous 
diffraction method (SAD) has been used for this work.  
In practice, selenium is one of the most widely used heavy atoms for 
SAD/MAD phasing in protein crystallography and was used for labeling 
proteins for this work. This approach was undertaken after unsuccessful 
molecular replacement trials using closely related structures. The structure of 
PhzM was solved from 360° Se-K-edge SAD data collected on ESRF-
beamline ID14/4. 16 out of 20 Selenium atoms were located by SHELXD 
(105). The structure of PhzS was solved from Se-K-edge SAD data collected 
at station ID29 of the ESRF. Of 360 1°-oscillation frames only the first 180 
were usable due to radiation-induced crystal decay. The positions of 8 
selenium atoms were determined by SHELXD and subsequently used for 
phasing in SHARP. 
 
Molecular replacement can be used when one has a good model for a 
reasonably large fraction of the structure in the crystal. If a homology model 
available, molecular replacement can be successfully employed to get phase 
information, which was first described by Rossmann & Blow. In this method, 
the phases for the model are obtained from the coordinates and the structure 
factor amplitudes (F
Calc
) of the known structure. In general the space group 
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and the orientation differ between the known and the unknown structure, 
therefore the known search model needs to be reoriented in the new unit cell 
properly. This is achieved by comparing the Patterson functions, obtained 
from the structure factor amplitude (F
Obs
) of the measured diffraction 
intensities and from the search model (F
Calc
). This fact was used to solve the 
structure of PhzM complexed with SAM 
 
3.5.5 Model Building and Refinement 
 
The initial structural model contains errors that can be minimised through 
iterative model refinement. This is a process of adjustment of the atomic 
coordinates of the model in order to minimise the difference between 
experimentally observed structure factor amplitudes (F
Obs
) and those 
calculated from the model (F
Calc
). The progress of refinement was monitored 
using the conventional crystallographic index ‘R factor’ and ‘R-free’. The R 
factor is defined by the equation: 
 
                   Σ    | Fobs (hkl)| –|Fcalc (hkl) | 
                            hkl    
     Rcryst (F)  =                             
                                                              Σ   | Fobs  (hkl) | 
                                                             hkl 
 
An acceptable value for the R-factor depends on the resolution of the 
structure. For structures determined at high resolution (<2.0 Å) the value of 
the final R-factor is expected to be below 0.2 or 20%. Given the low 
observations-to-parameters ratio for protein structures the R-factor can be 
artificially lowered at the expense of the stereochemistry of the model. To 
avoid this type of error, Brunger (1992) introduced a new methodology in the 
refinement process (cross validation) where approximately 5% of the data (a 
test group of reflections ‘T’) is isolated from the remainder (the working group) 
and not used for the purposes of refinement). Instead the refinement is 
performed by using only the reflections belonging to the working group. At 
each cycle of refinement the structure factors are calculated for both groups. 
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Whilst the working group is used for the calculation of the R-factor as defined 
above, the test group is used to calculate a new parameter, R-free, in an 
exactly analogous manner. 
 
 
 
 
 
The fundamental difference between these two discordance indices is that the 
refinement procedure `knows' about the working group (as it is used for the 
very refinement process) but it has never `seen' the test group. The great 
advantage of the R-free is that it is a sensitive indicator of over-refinement, 
that is, a refinement protocol, which attempts to extract more information than 
the data, is capable of providing. 
In case of PhzM the refinement program REFMAC5 (106) was used for 
refinement and the model further adjusted by hand using the graphics 
program O or COOT (107). For PhzS the refinement programme REFMAC5 
and CNS programme suit (108) was used and the model as in case of PhzM 
was further adjusted using O or COOT. 
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4.1 Cloning, over-expression and purification 
 
4.1.1 PhzM  
 
The oligonucleotide primers PhzM-up (5’-
TTTTTCATATGAATAATTCGAATCTTGCTG-3’) and PhzM-low (5’- 
TTTTTGGATCCGTTGAAAGTTCCGATTCA-3’) were used to generate a 1015 
base pairs DNA fragment encoding PhzM from P.aeruginosa PAO1 by 
Polymerase Chain reaction (PCR). This fragment was amplified with a PTC-
200 thermocycler. The PCR product was digested with NdeI and BamHI, gel-
purified, cloned behind a T7 promoter in the N-terminal His-tag fusion vector 
pET15b and single-pass sequenced to confirm the integrity of the resultant 
fusion. The plasmid was then transformed into E.coli Rosetta pLysS 
competent strain and initial expression tests were carried out to determine the 
optimal conditions for growth and expression. The protein was over-expressed 
(Fig.3.1 (a)) and purified according to the techniques mentioned earlier. A 
typical purification with nickel affinity chromatography and gel filtration (Fig.3.1 
(b)) produced about 95% of pure protein, which was concentrated to 20 
mg/ml. 
 
 
Fig 3.1 (a) Expression and nickel chromatography (M = marker; S= supernatant; I = 
induced; 1-8 fractions obtained after affinity chromatography) 
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 Fig.3.1 (b) Fractions obtained after gel purification 
 
The purification protocol for the Seleno-L-methionine labelled protein 
remained same as in the case of native protein. The purified protein was then 
used for the crystallisation trials.  
 
4.1.2 PhzS  
 
The oligonucleotide primers PhzS-up (5’- TATATACATATGAGCGAACCCATCGAT-
3’) and PhzS-low (5’- TTTTTTGGATCCTAGCGTGGCCGTTC-3’) were used to 
generate a 1218-bp DNA fragment encoding PhzS from P.aeruginosa PAO1 
by PCR. Like in case of PhzM the fragment was amplified, the PCR product 
was digested with NdeI and BamHI, gel-purified, cloned behind a T7 promoter 
in the N-terminal His-tag fusion vector pET15b and single-pass sequenced to 
confirm the integrity of the resultant fusion. The plasmid was then transformed 
into E.coli Rosetta pLysS competent strain and initial expression tests were 
carried out to determine the optimal conditions for growth and expression. The 
protein was over-expressed (Fig.3.2 (a)) and purified according to the 
techniques mentioned earlier. A typical purification with nickel affinity 
chromatography (Fig.3.2 (b)) and gel filtration (Fig.3.2 (c)) produced about 
95% of pure protein, which was concentrated to 15 mg/ml  
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Fig3.2 (a) Expression of PhzS in Rosetta pLysS strain (b) Fractions from Ni affinity 
column (FT = Flow through; I = induced; UI = uninduced; S = soluble extract ; 1-7 
are the fractions of the protein)   
 
 
Fig3.2 (c) Fractions from gel purification 
 
4.1.3 S-adenosylhomocysteine nucleosidase  
 
S-adenosyl-homocysteine nucleosidase is a 26-kDalton protein that 
hydrolyses S-adenosyl-homocysteine. As mentioned earlier SAH acts or 
creates a negative feedback regulation on the synthesis of the methylated 
RESULTS AND DISCUSSIONS 
 
 67
product so hydrolysing SAH thereby helps in the positive regulation of the 
methylation reaction. It was expressed in BL21pLysS strain, purified by the 
methods explained earlier (affinity chromatography and gel filtration) and 
concentrated to 10 mg/ml. 
 
 
 
 
 
Fig 3.3 (a) Expression of AdoHcy in BL21pLysS      Fig 3.3(b) Final purified fractions 
 
The purified fractions were then used for the biochemical assays in the 
experiments explained below. 
 
4.2 Crystallisation 
 
4.2.1 PhzM  
 
Crystallization was initiated at 293 K using the hanging-drop vapour diffusion 
method with Crystal Screen and Crystal Screen 2 from Hampton Research 
(100;101). 5, 10, and 15 mg/ml concentrations of protein in 20 mM Tris–HCl 
pH 8.0, 150 mM NaCl gel filtration buffer, were used for initial screening, with 
1.2 µl of protein solution mixed with a similar amount of precipitant. Conditions 
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that produced microcrystalline precipitates were optimized with respect to 
protein concentration, precipitant concentration and pH to reduce the amount 
of nucleation, increase the size and improve the appearance of the crystals 
obtained. Diffraction-quality crystals were obtained from a hanging drop 
containing 1.2 µl protein solution at 8 mg/ml mixed with the same volume of 
reservoir solution consisting of 18–23% (w/v) PEG 3350, 0.1 M sodium 
cacodylate pH 5.8–6.8, 0.2 M magnesium acetate. The drops were routinely 
equilibrated against 500 µl reservoir solution. The crystals have an oblique 
three-dimensional shape and take about two days to grow to dimensions of 
approximately 70 X 30 X 20 mm (Fig.3.2 (b)). Crystals of Seleno-L-
methionine- labelled PhzM were obtained under similar conditions (Fig.3.2 
(c)). 
      Fig 3.4 (a)                                                                        3.4 (b) 
 
                                     
                  
 
                                   
 
 
 
 
 
 
 
 
                       
 
Fig 3.4 (a) and (b) the native crystals of PhzM at different concentrations of PEG 3350 and pH  
 
 
 
 Fig. 3.4(c) Seleno-L-methionine labelled crystals 
of PhzM  
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4.2.2 PhzS  
 
Initial crystallization conditions were determined at room temperature with 
Crystal Screen and Crystal Screen 2 from Hampton Research (109;110). The 
protein concentration was screened at 10 and 15 mg/ml by dilution of the 
protein stock with gel filtration buffer. The hanging drop vapour diffusion 
method with drops consisting of 1.2 µl protein and 1.2 µl precipitant solution 
equilibrated against 500 µl reservoir volume at room temperature was used 
throughout. Conditions that produced microcrystalline precipitates were 
optimized with respect to protein concentration, precipitant concentration and 
pH to reduce the amount of nucleation and increase the size and appearance 
of crystals obtained. Diffraction-quality crystals were obtained at 12 mg/ml 
PhzS concentration and a reservoir with 0.7 - 1.0 M lithium sulfate, 0.1 M 
sodium citrate pH 5.0 - 5.5, 0.5 M ammonium sulfate. The crystals are yellow 
due to the presence of FAD and grow to a size of 0.3 × 0.3 × 0.2 mm (Fig.3.5 
(a))  in approximately 3 days. Seleno-L-methionine labelled crystals of PhzS 
(Fig. 3.5 (b)) grow as thin fragile plates and were obtained at two different 
conditions consisting of 14 - 17% (w/v) PEG 10000 / 0.1 M ammonium acetate 
/ 0.1M Bis-Tris pH 5.5 and 23 - 26% (w/v) PEG 3350 / 0.1 M Bis-Tris pH 5.8 – 
6.0 / 0.2 M ammonium sulfate. 
 
 
 
 
Fig. 3.5 Native (a) and seleno-L-methionine labelled (b) crystals of PhzS 
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4.3 Data collection, Structure Determination & Quality 
of Model 
 
Crystals obtained were exposed to synchrotron radiation and datasets were 
collected for structure solution. Molecular Replacement methods of structure 
solution being unsuccessful in both the cases, the structures were solved by 
SAD (Single-wavelength Anomalous Diffraction) using Seleno-L-methionine 
labelled protein. The initial steps of data processing and phase determination 
for all structures were similar and are described in detail in the previous 
section. The particulars of structure determination for each of the proteins are 
detailed below. 
 
4.3.1 PhzM and PhzM complexed with SAM 
 
In order to achieve cryoprotection, PhzM crystals were washed briefly in 
mother liquor supplemented with 10% (w/v) sucrose and 10% (w/v) xylitol and 
flash-cooled in liquid nitrogen prior to data collection The crystals belong to 
space group P1, with unit-cell parameters a = 46.1, b = 61.8, c = 69.6 Å, α= 
96.3, ß = 106.6, γ = 106.9°. Diffraction spots appear to be split in one 
orientation; however, data reduction statistics as shown below are 
nevertheless satisfactory.  
 
A data set was collected from a native protein crystal at 100 K as 180° non-
overlapping 1º oscillation λ=0.9758Å images at ID14EH1 of the European 
Synchrotron Radiation Facility (ESRF, Grenoble, France) using a MAR 165 
CCD detector with 10 s exposure time. 
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DATA 
COLLECTION 
 
NATIVE  
 
Se-SAD 
 
PhzM complexed 
with SAM 
 
Wavelength (Å) 
 
0.934 / ID14EH1 
 
0.9758 / 
ID14EH4 
 
0.979/ ID29 
Resolution 
(Highest Shell, Å) 
 
20-1.75 (1.9-1.8) 
 
20-2.3 (2.4-2.3) 
 
20-1.85 (1.95-
1.85) 
 
Space group 
 
P1 
 
P1 
 
P21 
 
Cell constants 
 
a=46.1, b=61.8, 
c=69.5; 
α= 96.3, β =106.5, 
γ =106.9 
 
a=46.4, b=61.8, 
c=69.8; 
α= 96.1, β 
=106.8, γ 
=107.1 
 
a=63.3, b=73.7, 
c=72.8; 
α= 90, β =91.6, γ 
=90 
 
VM 
 
2.4 
 
2.1 
 
4.3 
 
Total 
measurements 
 
161889 
 
117778 
 
228850 
Unique 
Reflections 
61771 59061 56959 
Average 
Redundancy 
2.6 2.01 4.5 
I/σ 11.27 (3.9) 9.57 (5.5) 13.69 (3.07) 
Completeness (%) 95.7 96.1 99.4 (100) 
Anom. 
Completeness 
(%)a 
- 96.0 - 
Rsymb 8.0 (33.1) 6.0 (14.5) 7.0 (44.4) 
aCompleteness calculations treat Friedel pairs as separate observations 
bRsym = Σ | I(h)j - <I(h)> | / Σ I(h)j where I(h)j is the scaled observed intensity of 
the i-th symmetry-related observation of reflection h and <I(h)i> is the mean 
value 
 
Radiation damage precluded higher redundancy data collection. A single 
strong peak in the κ = 180° section of the self-rotation function reveals the 
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orientation of one PhzM dimer in the asymmetric unit (Fig.3.6), corresponding 
to a solvent content of 47%. 
 
 
 
Fig.3.6 κ = 180° section of the self-rotation function of the native PhzM data set, 
calculated with REPLACE (Tong & Rossmann, 1997). Search angle, polar XYK; 
orthogonalization, AXABZ. 
 
As molecular replacement was not successful, the structure of PhzM was 
solved from 360° Se-K-edge SAD data collected on ESRF-beamline ID14/4. 
16 out of 20 expected selenium atoms were located by SHELXD (105). 
Subsequent refinement, phasing and density modification was carried out in 
SHARP (111) including data of a native crystal to 1.8 Å resolution. This 
allowed determining the handedness of the system but the resulting electron 
density was of poor connectivity, making de novo tracing impossible. It was, 
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however, sufficient for positioning of a related structure (Caffeic acid 3-o-
methyltransferase, PDB-access code 1KYZ) within the solvent boundary and 
to use this structure as a guide for editing bones in O (112). It became 
obvious that the two PhzM monomers contained in the AU possess a different 
domain arrangement and that two different operators should be used in NCS 
averaging. Subsequent density modification in DM (105;113-115) yielded 
excellent electron density, which was then used in RESOLVE to automatically 
build a partial model. Using the Se atoms as anchor points and bulky aromatic 
(Trp, Tyr, Phe) residues as “light houses”, side chains were incorporated into 
this poly-alanine model and 330 of the total 334 residues (per monomer) were 
fitted. The first 4 residues could not be fitted, as there was no electron density 
in that region. This model was then further refined using the program 
REFMAC5 (106). The structure was completed by hand in O and refined with 
REFMAC5 (106). 
 
The current model of dimeric PhzM consists of 330 residues starting with 
residue number 4, which codes for Ala till Ala 334 (per monomer). The final 
structure of PhzM at 1.75 Å resolution has R-factor of 13.9% and Rfree of 
18.4%. The Ramachandran plot (Figure 3.7) obtained by the validation 
programme ‘PROCHECK’ shows 92.9 % of the total amino acids in the most 
favoured region 7.0 % and 0.2 % in the additionally allowed and generously 
allowed regions respectively. The model of PhzM complexed with SAM has a 
final resolution of 3.2 Å and contains one SAM molecule per dimer in addition 
to the molecules present in the native structure. Of the total residues for both 
the native and complex structure, 92.2% lie in the most favoured region of the 
Ramachandran plot (PROCHECK) (116). Most of the residues with poorer 
electron density are located in the additionally allowed regions, with two 
residues in the disallowed region. The final data collection statistics for the 
structure of PhzM and its complex with SAM are tabulated in page no 73 
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Fig 3.7 Ramachandran plot of the final model of PhzM. 
 
4.3.2 PhzS 
 
To achieve cryoprotection prior to data collection, PhzS crystals were washed 
briefly in mother liquor supplemented with 10 % (w/v) sucrose and 10 % (w/v) 
xylitol and then flash cooled in liquid nitrogen. Crystals of the native protein 
belong to the C2 group with the cell parameters a = 144.2, b = 96.2 and c = 
71.7 Å; α = γ = 90, β = 110.5°, indicative of two PhzS monomers contained in 
the asymmetric unit. A data set of a native protein crystal to 2.4 Å resolution 
was collected at 100 K in 110 non-overlapping 1º oscillation images at 
ID14EH1 of the European Synchrotron Radiation Facility (ESRF, Grenoble, 
France), using a MAR165 CCD detector with 10s exposure time.  
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DATA COLLECTION 
 
Se SAD 
 
NATIVE  
Wavelength (Å)a 0.9791 / E-ID29 0.931 / E-ID14/3 
Resolution (Highest 
Shell, Å) 
20.0 – 2.7 (2.8 –2.7) 20.0 – 2.4 (2.5 –2.4)  
 
Space group 
 
C2 
 
C2 
 
Cell constants 
a=70.6, b=76.2, 
c=80.2; 
α= γ =90, β =110.5 
 
a=144.2, b=96.2, c=71.7; 
α =γ=90, β=102.7 
VM 2.3 2.8 
Total measurements 40759 141768 
Unique Reflection 10933 37329 
Average Redundancy 3.8 (3.7) 3.8 (3.8) 
I/σ 11.3 (5.3) 18.6 (3.2) 
Completeness (%) 98.9 (100) 99.7 (99.3) 
Anom. Completeness 
(%)b 
96.8 (97.1) - 
Rsymc 7.5 (24.9) 5.7 (46.8) 
Wilson B-factor (Å2) 43 47 
R-merge% 8.5 (26.9) 9.3 (50.1) 
 
Data collection statistics for PhzS 
bCompleteness calculations treat Friedel pairs as separate observations 
cRsym = Σ | I(h)j - <I(h)> | / Σ I(h)j where I(h)j is the scaled observed intensity of the i-
th symmetry-related observation of reflection h and <I(h)i> is the mean value 
 
SAD data from a Seleno-L-methionine labeled crystal were collected at 100K 
from 360 non-overlapping 1º oscillations at λ = 0.975756 Å (Se-absorption 
edge) at ID29 of the same synchrotron, using a Quantum (Q4R)-ADSC 
detector with 1.5 s exposure time and three passes per image. These crystals 
belong to space group C2 as well, however they possess different unit cell 
parameters of a = 70.6, b = 76.2 and c = 80.2 Å; α = γ = 90, β = 110.5°, 
allowing for the presence of one PhzS monomer in the asymmetric unit only.  
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Fig 3.8 Harker section at v = 0 contoured at 3 σ, calculated from the anomalous 
differences of the Se-SAD data. 
The crystals diffract to a resolution of 2.7 Å and are radiation sensitive. Peaks 
in the Harker section at v = 0 (Fig. 3.8) indicate the presence of anomalous 
scatterers. 
The structure of PhzS was determined from Se-K-edge SAD data collected at 
station ID29 of the ESRF. Of 360 1°-oscillation frames only the first 180 were 
used due to radiation-induced crystal decay. The positions of 8 selenium 
atoms were determined by SHELXD and subsequently used for phasing in 
SHARP. The resulting electron density was poor and it was not possible to 
use the phase set for the better native data in the other crystal form. Instead, 
a related structure (p-hydroxybenzoate hydroxylase, PDB-access code 1PHH) 
was positioned within the solvent boundary and used as a guide to edit bones 
in O. The resulting trace was used to trim a poly-alanine version of 1PHH, 
resulting in a rough model, which was refined against the selenium-derivative 
data in REFMAC5. A crystallographic dimer was constructed and used as a 
molecular replacement model for the native data in PHASER. A unique 
solution was obtained and the superimposition operators with respect to the 
selenium-derivative were used in DMMULTI (106;115;117-120) for cross 
crystal averaging, starting from the experimental phase set. The resulting 
electron density was of good quality and was used for model building. 
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Fig 3.9 Ramachandran plot of the final model of PhzS. 
 
The current model of dimeric PhzS consists of 384 residues starting with 
residue number 4 which codes for Pro till E384 (per monomer). The final 
structure of PhzS at 2.4 Å resolution has R-factor of 20.3% and Rfree of 22.9%. 
The Ramachandran plot (Figure 3.9) obtained by the validation programme 
‘PROCHECK’ shows 85.6 % of the total amino acids in the most favoured 
region 13.4 % and 0.6 % in the additionally allowed and generously allowed 
regions respectively.  
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4.4 Structural Analysis 
 
4.4.1 Structural Analysis of PhzM from Pseudomonas 
aeruginosa 
 
4.4.1.1 Monomer of PhzM 
 
PhzM is a dimeric protein with a monomer molecular weight of 36.2 kDa. It is 
a SAM dependent methyltransferase comprising of two identical single 
subunits of 334 amino acids each. Each polypeptide of PhzM is built up of 
fifteen helices and seven ß-strands and comprises of three domains, the N-
terminal domain, a middle domain and the C- terminal domain (Figure 3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.10 Three domains of PhzM 
 
The N-terminal domain mainly consists of alpha helices and spans residues 
from 1-95. It is the dimerisation domain and contains five helices. It forms 
relatively few contacts with the other domains of the subunit, but is involved in 
an extensive dimerisation interface (Figure 3.11 (a)). 
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Fig 3.11 (a) and (b) First two domains 
 
The middle, the second domain is made up of residues 96-168 and is all 
helical (Figure 3.11 (b)).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.11 (c) The third domain 
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The C- terminal domain, comprising amino acid residues 169-334 has the 
typical α/ß fold commonly found in nucleotide binding proteins (Figure 
3.11(c)). The C-terminal domain has a structure typical of most small molecule 
methyltransferases, many of which have been characterized structurally. 
Domain III contains the SAM binding site, has a Rossmann-like fold, and 
consists of a ß-sheet with a strand topology 3214576 where all except ß7 are 
parallel to each other. This domain consists of the conserved nucleotide 
binding fingerprint (DLGGGxG) and SAM binds at the carboxy end of the ß-
sheet (Figure 3.12). 
 
 
 
Fig 3.12 Sequence alignment of PhzM with other homologues proteins. The SAM 
binding motif shown in red arrows 
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4.4.1.2 Dimer of PhzM and dimer interface 
 
The N-terminal domain plays an important role in the dimerisation of PhzM. 
The figure below (Figure 3.13) shows the dimer of PhzM with monomers 
highlighted in two different colours. 
Fig 3.13 Dimer of PhzM 
 
he dimer interface is formed mainly by Domain I, the N-terminal domain T
comprising of five helices and one helix from the C- terminal domain. Of the 
residues participating in the dimer interactions, 55% are polar, 45% non-polar 
residues. 
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  Polar 
Residues 
Asn5, 11, 81; Arg10, 23, 30, 57, 60, 63, 76, 89, 96; Q14, 72; 
Thr17, 29, 46, 75, 82, 84, 111, 121; Glu19, 38, 45, 56, 69, 92, 
104, 105, 115, 125, 130; Lys21; Ser22, 39, 43, 53, 85, 94, 119, 
284; Cys24; 114; Tyr26, 79, 102; Asp35, 42, 44, 54, 74, 77, 90, 
97, 131, 288; His59, 86, 107, 290;  
 
Non- Polar 
Residues 
Leu6, 12, 31, 33, 36, 47, 61, 64, 65, 87, 88, 100, 117, 118, 126, 
286, 291; Ala7, 8, 9, 28, 34, 48, 49, 50, 55, 67, 80, 108, 109, 
113, 116, 127; Ile13, 37, 41, 58, 70; Val15, 16, 25, 27, 51, 66, 
91, 99, 285, 289; Gly18, 32, 40, 52, 63, 68, 93, 103, 120, 123, 
129; Trp20, 110, 287; Met62, 98, 283, 293; Phe68, 71, 95, 101, 
106, 124, 132, 292; Pro83, 112, 122, 282 
 
4.4.1.3 PhzM and homologues structures 
The polypeptide chain of PhzM from Pseudomonas aeruginosa consists of 
334 amino acids and shows significant sequence identity with several SAM-
binding enzymes deposited in the structure database PDB (citation PDB: H.M. 
Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. 
Shindyalov, P.E. Bourne: The Protein Data Bank Nucleic Acids Research, 28 
pp. 235-242 (2000).), including isoflavone O-methyltransferase (24 % 
sequence identity, PDB-access code 1fp2; Zubieta et al., Nat.Struct.Biol. v8 
pp.271-279, 2001), carminomycin-4-O-methyltransferase (sequence identity 
26 %, PDB access code 1tw2; Jansson et al., C v279 pp. 41149-56, 2004), 
aclacinomycin-10-hydroxylase (sequence identity 24 %, PDB access code 
1qzz; Jansson et al., J.Mol.Biol. v334 pp.269-280 , 2003) and caffeic acid 3-
O-methyltransferase (24 % sequence identity, PDB-access code 1kyz;(121) 
(Figure 3.14). 
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Fig 3.14 Superimposition of PhzM and other related structures 
These relatives belong to the class of small molecule SAM-dependent 
methyltransferases (122) and like these enzymes, PhzM contains the 
DXGGGXG fingerprint motif, characteristic for the nucleotide-binding site of S-
adenosyl-L-methionine. However, unlike the related proteins listed above, 
PhzM transfers a methyl group to a nitrogen atom and our data therefore 
present the first efforts toward the structure of a phenazine-specific small 
molecule N-methyltransferase. 
4.4.1.4 SAM binding site or the C-terminal domain 
 
Like the homologous structure of PhzM the binding site for the cofactor SAM 
of PhzM is located in the domain III at the C-terminal ends of the first two ß-
strands of the large ß sheet (Figure 3.15). SAM is bound to the protein 
through an extensive hydrogen bond network. 
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Fig 3.15 Dimer of PhzM showing the SAM binding site 
 
 
 
The carboxyl group of the SAM molecule interacts with the hydroxyl group of 
side chain of Ser240 and amino group of Arg241. The amino group of SAM is 
anchored to the main chain carbonyl oxygen atom of Gly175. The ribose 
moiety forms hydrogen-bonding interactions via the two hydroxyl groups to the 
side chain of Asp198. The main chain carboxyl oxygen atom of Asp225 form 
hydrogen bonds to the amino group on the adenine ring (Figure 3.16) 
 
 
 
 
 
RESULTS AND DISCUSSIONS 
 
 85
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.16 Interaction of SAM with the residues of PhzM shown by blue dotted lines 
 
PhzM unlike the majority of methyltransferases is a dimer. The fold 
categorizes PhzM as a class I methyltransferase. In comparison, the two 
crystal forms reveal a dramatic movement of the SAM binding domain, which 
moves up to 8 Angstroms between the two structures (Figure 3.17).  
 
 
Fig 3.17 The two forms of PhzM open and closed 
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In the closed, SAM bound form, a substrate-binding site large enough for 
accepting a tricyclic phenazine molecule is generated (Figure 3.18). Modelling 
shows how the substrate is positioned for methyl transfer from the cofactor. In 
(Figure 2.18) the tricyclic phenazine molecule considered is PCA since till now 
studies have tried to prove PCA being the substrate. However, in this study 
we have found through biochemical assays that it is infact 1-oh-phenazine 
which is the substrate for the enzyme PhzM. Therefore, crystal structure of 
PhzM complexed with 1-oh-phenazine will help us to prove the same. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.18 Interaction of the substrate with SAM 
 
4.4.2 Structural Analysis of PhzS from Pseudomonas 
aeruginosa 
 
PhzS (FAD or flavin dependent mono-oxygenase) is a dimeric protein 
comprising of two identical single subunits of 402 amino acids each with a 
monomer molecular weight of 43.6 kDa. 
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                Fig 3.19 PhzS dimer with the two subunits coloured in green and blue 
 
4.4.2.1 Monomer of PhzS  
 
The polypeptide of PhzS is composed mainly of 3 domains (Figure 3.20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.20 Monomer of PhzS with three domains 
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The N-terminal domain represents the FAD binding domain spanning residues 
from 4 to 163 and has a βαβ fold formed by strand A1 (6-11); helix H1 (14-28) 
and strand A2 (30-36).  
 
 
 
 
 
 
 
 
 
 
 
Fig 3.21 (a) showing the first domain 
 
This fold binds the adenosine part of the FAD (Figure 2.21 (a)). The partial 
positive charge induced by the dipole moment of helix (H1) helps to 
compensate for the negative charge of the pyrophosphate moiety of the FAD. 
The same βαβ conformation has been observed in many NAD(P)H using 
enzymes(123). 
 
 
Fig 3.21 (b) and (c) showing the second and the third domain 
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The second domain spanning residues from 164 to 290 consists of a ‘wall’ of 
β- sheets ranging from 205 to 290 (Figure 3.21 (b)).  
The third domain, the interface domain spans residues from 291 to 380. This 
C-terminal domain is dominated by two helices Gly322 - Arg339 and Val343 –
Ala376  (Figure 3.21(c)). 
 
4.4.2.2 The Rossmann fold 
 
Like other dinucleotide binding proteins PhzS also exhibits conserved 
sequence motifs at positions crucial for binding substrates and cofactors. One 
of the fold is termed as the Rossamann fold (124) that consists of six parallel 
ß-strands interspersed by α -helices that appear on both sides of the six-
stranded ß sheet. This symmetrical α/ß structure is built from two halves ß1 α1 
ß2 α2 ß3 and ß4 α4 ß5 α5 ß6 with a crossover α helix (α3) connecting ß3 and ß4 
(Fig. 3.22).  
 
 
Fig 3.22 Each of the motifs is known as the classical mononucleotide-binding motif or 
the Rossmann fold. Cylinders represent α-helices and arrows denote ß-strands. The 
overall pseudo two-fold rotation symmetry between the two ßαßαß motifs is shown by 
an arrow. 
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Each of these folds is known as the classical mononucleotide binding fold or 
the Rossmann fold. A variation of this fold is found in the FAD binding 
proteins. 
 
Amongst the entire FAD binding proteins the most thoroughly studied family is 
that of the glutathione reductase (GR) family. PhzS resembles the well-
studied p-hydroxybenzoate hydroxylase, which belongs to the GR family and 
more specifically to the GR2 family. The Rossmann fold is seen in both the 
families, however with some exceptions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.23 (a) FAD binding motif 
 
Fig. 3.23 (a) shows the Rossmann fold adopted by the GR family members. 
PhzS also shows a more or less similar fold in the FAD binding motif. 
However in PhzS the ß3 and ß4 are connected through two small crossover α 
–helices instead of 3-strand ß-meander.  
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Fig 3.23 (b) FAD binding motif in PhzS 
 
The most conserved and well-studied sequence motif is part of the Rossmann 
fold, xhxhGxGxxGxxxhxxh(x)8hxhE(D), where ‘x’ is any residue and ‘h’ is a 
hydrophobic residue (125-127) (Fig. 3.23 (b)). This motif is found at the N-
terminal part of the sequence. Like the GR family PhzS also has this motif 
starting from residue number Ile7 to Glu35. The central part of the sequence 
motif of the Rossmann fold i.e., GxGxxG, is part of loop connecting the first ß-
strand and α –helix in the ßαßαß fold with the N-terminal end of the α –helix 
pointing to the pyrophosphate moiety of FAD for charge compensation. This 
consensus is known as the dinucleotide binding motif (DBM) (127) or the 
phosphate binding sequence signature (128).  
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Fig 3.24 Structure of PhzS showing the Rossmann fold 
 
In the GxGxxG motif of the FAD binding domain in PhzS, the first strictly 
conserved glycine residue (Gly 11) allows for the tight turn of the main chain, 
which is important for the positioning of the second glycine residue. This (Gly 
13) residue on the other hand because of its missing side chain, permits close 
contact of the main chain to the pyrophosphate of FAD, specifically the 
oxygen atoms. The third glycine (Gly 15) allows close packing of the helix with 
the ß –sheet (Fig. 3.25).  
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Fig 3.25 GxGxxG motif of FAD binding domain 
 
The hydrophobic residues provide hydrophobic interactions of the alpha helix 
with the ß-sheet. The conserved negatively charged terminal residue (Glu35) 
at the end of this FAD binding motif, forms hydrogen bond with the ribose 2’-
hydroxyl of the adenosine moiety. 
 
4.4.2.3 Dimer of PhzS and dimer interface 
 
The dimer interface is formed mainly by Domain I, the N-terminal domain 
comprising of five helices and one helix from the C-terminal domain. Of the 
residues participating in the dimer interactions, 28% are polar, 59% non-polar 
residues. 
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Fig 3.26 The PhzS dimer showing the dimer interface 
 
 
Polar 
Residues 
Asn48, 97; Q25, 50, 81, 101, 123, 124, 154; Thr32, 69, 73, 85, 128; 
Glu3, 35, 39, 55, 59, 75, 89, 94, 108, 119, 133, 137, 138; Lys30; 
Cys19; Tyr78, 99, 102; Asp139, 148, 159; His24, 74, 105, 150; 
Ser2, 8, 36-38, 82, 88, 103 
 
Non- 
Polar 
Residues 
Leu7, 17, 21, 23, 33, 34, 43, 57, 60, 62, 66, 76, 109, 121, 130, 143, 
156, 161; Ala10, 12, 20, 22, 26, 52, 53, 56, 58, 65, 67, 68, 70, 84, 
95, 98, 115, 116, 125, 146, 155, 158; Ile 5, 7, 9, 14, 28, 40, 47, 49, 
71, 79, 104, 112, 135, 144; Val31, 45, 54, 86, 93, 117, 126, 132, 
142, 160, 162; Gly11, 13, 15, 16, 27, 29, 44, 46, 61, 63, 83, 92, 96, 
107, 122, 129, 131, 140, 145, 149, 151, 157, 163; Trp87; Met1, 111; 
Pro4, 42, 51, 64, 72, 90, 100, 153 
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4.4.2.4 PhzS and the homologues structure 
 
Predictions from the fold recognition programme 3D PSSM (129) indicate that 
PhzS possesses significant fold similarity with FAD-dependent 
oxidoreductases and indicate 17% sequence similarity with p-
hydroxybenzoate hydroxylase (PDB access code 1PHH;(130), a flavoprotein 
involved in the degradation of aromatic compounds and a model for enzymes 
involved in the oxygenation of a substrate (Fig. 3.27).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.27 Superimposition of 1PHH and PhzS 
 
Both PhzS and p-hydroxybenzoate hydroxylase belong to the class of FAD-
dependent monooxygenases. These enzymes catalyse the insertion of one 
atom of dioxygen into a variety of substrates while the other oxygen atom is 
reduced to water. The monooxygenases use an external reducing agent to 
provide electrons to reduce oxygen to the level of hydrogen peroxide, which is 
then responsible for the insertion of oxygen into the substrate. These 
enzymes are reduced by NAD(P)H to give FADH2, which then binds molecular 
oxygen to form a spectroscopically characterized highly reactive peroxide-
linked flavin. This intermediate is decomposed by the nucleophilic attack of an 
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adjacent substrate, resulting in oxygen atom transfer(131). In PhzS, this leads 
to a decarboxylation of the substrate with concomitant incorporation of a 
hydroxyl group. 
 
The C-terminal domain 
 
The C-terminal region of both PhzS and 1PHH is dominated by helices. In case 
of 1PHH apart from the two long helices 
spanning residues from 298 to 358 there are 
two short helices as well which is not seen 
in PhzS. However this is because of the 
absence of the electron density for the last 
22 residues in PhzS in one of the 
monomers. In 1PHH the function of helix 
H10 seems merely to be giving the molecule 
rigidity; helix H10 has an important function 
in catalysis. It stabilises the negative charge 
of the flavin ring after its reduction. Secondly 
plays an important role in the removal of 
NADP+ from the active site due to electrostatic repulsion of the positively 
charged oxidised nicotinamide.  
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Fig 3.28 (b) The difference in the conformation of FAD in PhzS and 1PHH 
 
However in case of PhzS although the flavin ring is in the elongated 
conformation but the degree of extension of the cofactor is different compared 
to 1PHH. This conformational flexibility allows the substrate to gain access to 
the active site and excludes solvent during the hydroxylation reaction. 
Other than 1PHH, PhzS also shows some fold similarity with one more FAD 
dependent hydroxylase (1foh or phenol hydroxylase) but only to a minute 
extent. This is the reason why only 1PHH has been taken into consideration 
for better understanding of the protein being investigated. 
 
4.4.2.4 Getting an idea about substrate binding in PhzS from the function 
of 1PHH 
 
1PHH or p-Hydroxybenzoate hydroxylase catalyses the hydroxylation of p-
hydroxybenzoate (pOHB) to form the catechol 3,4-dihydroxybenzoate. 
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Fig 2.19 Catalytic cycle of p-hydroxybenzoate hydroxylase 
 
1PHH, like other flavoprotein aromatic hydroxylases, activates molecular 
xygen by forming a C4a-hydroperoxyflavin. The distal peroxy oxygen is then 
corporated into the aromatic substrate. 
 
 
 
 
Fig 2.20 (a) 1PHH complexed with substrate 
 
 
o
in
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The crystal structure of 1PHH shows that the carboxyl moiety of the substrate 
pOHB interacts with three active site residues, Arg214, Tyr222 and Ser212 
(Fig 2.20 (a)).  
 
These residues form hydrogen bonds with the substrate carboxylate, one 
each from both Tyr222 and Ser212, and two from the ion paired Arg214. This 
helped us to construct a model of PhzS complexed with the substrate. The 
model reveals that in the crystal form studied in this case is in the oxidized 
form, expecting reduction by the cosubstrate NAD(P)H. following reduction, 
the isoalloxazine moiety will swing towards the substrate binding site, initiation 
decarboxylation-hydroxylation of the substrate phenazine-1-carboxylic acid or 
PCA. Thus, in normal catalysis flavin or the isoalloxazine ring moves to the 
out position so that the substrate can be bound, and then the flavin moves 
back in to exclude solvent and prevent it from interfering with the 
hydroxylation reaction (Fig. 2.20 (b)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.20 (b) The movement of the isoalloxazine ring in the PhzS structure 
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4.5 Biochemical analysis of proteins 
 
4.5.1 Isothermal Titration Calorimetry 
 
To find the interaction of SAM with PhzM we used ITC experiment. The result 
of the titration experiment, in which a fixed amount of PhzM was titrated 
against increasing concentration of SAM is shown in Figure 2.21.From the 
data the value of the binding constant (KB ) was found to be 1.94 x104  giving 
us the value of the dissociation constant (KD ) as 51µM using the formula 
 
KB  =  1/ KD = 1/ 1.94 x 104 
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Fig 2.21 The binding of SAM with PhzM 
 
Although the binding of the substrate SAM with PhzM is not strong enough but 
it gave us an idea of cocrystallising the substrate with the enzyme to get an 
insight of the binding through crystallographic technique. 
 
RESULTS AND DISCUSSIONS 
 
 101
4.5.2 HPLC-APCI-MS 
 
As mentioned earlier that there are two hypothetical reaction mechanisms for 
the biosynthesis of pyocyanin as can be seen in (Fig. 2.22). In order to get an 
insight to the reaction mechanism this was one of the methods employed.  
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Fig 2.22 The reaction pathways 
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4.5.2.1 Pyocyanin biosynthesis 
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Fig 2.23(a) The change in the concentration of pyocyanin 
 
 Substrate (100 µM) Cosubstrate 
(1mM) 
Enzyme (10 µM) 
PCA SAM PhzM 
 NADH PhzS 
 NADPH AdoHcy 
 
 
 
 
 
 
First of all the overall formation of pyocyanin was monitored and was plotted 
as in the (Figure 2.23 a)). For the above reaction mixture as shown in the 
table the effect on the concentration of pyocyanin is seen when the enzymes 
are mixed with the specific substrates. However there is a difference in the 
concentration of pyocyanin formed and this variability is effected by the 
presence of NADPH and NADH in the reaction mixture. As we can see from 
the graphical representation that concentration of pyocyanin is much higher in 
presence of NADPH as compared to NADH. In addition to this there is one 
more difference that can be seen is the effect on pyocyanin in presence and 
absence of AdoHcy enzyme showing that this enzyme also plays certain role 
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in the biosynthesis of pyocyanin to some extent. As mentioned earlier in 
section1.8.2 AdoHcy helps in curbing the action of SAH, the negative 
regulator of methylation reactions. 
 
SAH concentration
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Fig 2.23(b) The effect on SAH in presence of AdoHcy 
 
Substrate  
(100 µM) 
Cosubstrate 
(1mM) 
Enzyme  
(10 µM) 
PCA SAM, NADH, 
NADPH 
PhzM, PhzS, 
AdoHcy 
 
 
As we can see the concentration of SAH varies with the presence and 
absence of AdoHcy (Figure 2.23 (b)The amount of SAH formed in absence of 
AdoHcy is almost negligible compared to what is seen in presence of AdoHcy. 
Thus it can be concluded that for the better productivity of pyocyanin, it is 
much better to use AdoHcy in the reaction mixture. Thus, the hydrolysis of 
SAH by the nucleosidase enzyme increases the yield of pyocyanin in the 
reaction. 
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Next step was to determine the PCA concentration as the reaction proceeds 
leading to the formation of pyocyanin. Same reaction mixture with similar 
concentration was considered and the effect on the concentration of PCA was 
observed. 
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Fig 2.23(c) The consumption of PCA 
 
Substrate  
(100 µM) 
Cosubstrate 
(1mM) 
Enzyme  
(10 µM) 
PCA SAM, NADH, 
NADPH 
PhzM, PhzS, 
AdoHcy 
 
From the Figure 2.23(c) we can see that in all the conditions leading to the 
formation of pyocyanin the consumption of PCA is complete. However in order 
to get an insight on the concentration of PCA in presence of only each of the 
enzyme studies were carried out in presence of either PhzM or PhzS in 
presence of their specific substrates. In one more study done in our group on 
the biosynthesis of phenazines, it was found that the end product of the ‘core’ 
phenazine biosynthesis pathway in presence of the seven enzymes PhzA-G is 
reduced form of PCA. So the reduced form of PCA was also used to monitor 
the action of either of the enzymes PhzM or PhzS. So the first test was carried 
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out using PhzM along with SAM and AdoHcy. In order to reduce PCA in this 
case two reducing agents Sodium Dithionite (Na2S2O4) and NADPH were 
used. 
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Fig 2.23(d) The consumption of reduced and oxidized PCA in presence of PhzM 
 
Substrate  
(100 µM) 
Cosubstrate 
(1mM) 
Enzyme  
(10 µM) 
Reducing agent 
PCA, 1-oh-phz SAM, NADH, 
NADPH 
PhzM, PhzS, 
AdoHcy 
Na2S2O4 (5mM) 
 
In presence of the single enzyme PhzM both, PCA as well as the reduced 
form PCA does not show any significant decrease in concentration (Figure 
2.23(d)). This result shows that the methylation reaction didn’t work efficiently 
implying that the PCA (oxidized and reduced form) didn’t undergo methylation 
process and thus not a substrate of PhzM. 
To check the influence of the other enzyme PhzS involved in the biosynthesis, 
the same technique was used. In this case also the reduced form of PCA was 
used as well.  
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Fig 2.23(e) The consumption of reduced and oxidized PCA in presence of PhzS 
 
From (Figure 2.23(e)) it can been seen that in one of the condition the 
reduced PCA concentration completely falls to zero compared to what it was 
seen in the case of PhzM. In addition to this the amount or the concentration 
of PCA really goes down when a higher concentration of Sodium dithionite 
was used. This decrease in the concentration of PCA proves that the reduced 
form of PCA is a good substrate for PhzS. So the next step was to check the 
formation of the product, which is formed by the monooxydative 
decarboxylation of PCA leading to the formation of 1-hydroxy-phenazine. 
(Figure 2.23(f)) shows the difference in the concentration of 1-hydroxy-
phenazine. It can be seen that the concentration or the formation of 1-
hydroxy-phenazine is highest in the presence of sodium dithionite when it was 
used at a high concentration. 
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Fig 2.23(f) The formation of 1-oh-phenazine 
 
The next in the pathway is to check the conversion of 1-hydroxy-phenazine to 
pyocyanin in presence of the second modifying enzyme PhzM in presence of 
SAM. So from (Figure 2.23(f)), the condition, which gave the highest 
concentration of the oxidative product from PCA, was used to check the 
methylation reaction. The formation of the product reaches the saturation level 
at a certain point and at this stage the second modifying enzyme is added 
along with SAM and AdoHcy enzyme (Figure 2.23(g)). 
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Fig 2.23(g) 
 
However as the reaction is allowed to proceed the concentration of the 
substrate which is 1-hydroxy-phenazine doesn’t vary showing that the 
methylation process is not successful and thus there is no production of 
pyocyanin. Theoretically it can be explained on the basis of the stability of 1-
hydroxy-phenazine. When the concentration of 1-hydroxy-phenazine reaches 
the saturation level it is in its stable state and because of which the transfer of 
methyl group is not possible. But if its reduced to some extent then may be 
methylation will result the formation of pyocyanin. 
 
So from the biochemical assays we can conclude that the pathway which was 
proposed earlier being PhzM as the first enzyme is not feasible. Moreover it is 
the reduced form of PCA the end product of the phenazine biosynthesis, 
which from our assays seems to be the starting product for pyocyanin 
biosynthesis. Thus the biosynthesis of pyocyanin involves the formation of 1-
oh-phenazine in presence of the enzyme PhzS followed by the conversion of 
this reactant into the final product (Figure 2.24). 
 
RESULTS AND DISCUSSIONS 
 
 109
 
Fig 2.24 The concluded pathway 
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5.0 Summary 
Phenazines as secondary metabolites have caught the interest of the 
researchers since the 19th century. Amongst all the phenazine producing 
organisms most studies have been focussed on Pseudomonas species. The 
pathway leading to the biosynthesis of phenazines branches off from the 
Shikimic acid pathway. Apart from the seven gene operon leading to the 
biosynthesis of phenazine-1-carboxylic acid or PCA, there are some additional 
genes involved in the biosynthesis of other phenazine compounds. Genes 
phzm and phzs are couple of them, which are responsible for the conversion 
of PCA to pyocyanin. Pyocyanin a member of this large family of compounds 
called phenazines is toxic at molar concentration to a wide range of bacterial 
and mammalian cells. Although the research on pyocyanin dates back to early 
years, very little is known about the enzymes involved in its biosynthesis. This 
work helps us to understand the structure of the enzyme involved in its 
biosynthesis as well as provides an insight on the mechanism behind 
pyocyanin biosynthesis. 
 
The structure of PhzM has been solved by SAD using Se-labelled protein. The 
final structure of native PhzM has been resolved to a resolution of 1.8Å and 
has R-factor of 13.9% and Rfree of 18.4%. The structure of PhzM indicates that 
like other methyltransferases, it has a SAM binding site showing the 
Rossmann like fold and is similar to a family of previously characterised plant 
o-methyltransferases. The fold of the SAM binding domain of PhzM 
categorises this enzyme as a Class I methyltransferases. Moreover the 
structure of PhzM complexed with its cosubstrate SAM showed an open and 
close transition of PhzM and also helped to further understand and clarify its 
role as a methyltransferase in pyocyanin biosynthesis. 
 
The structure of PhzS has been also solved by SAD using Se-labelled protein. 
The final structure of native PhzS has been resolved to a resolution of 2.4Å 
and has R-factor of 20.3% and Rfree of 22.9%. Enzyme PhzS shows sequence 
similarity to p-hydroxybenzoate hydroxylase, of the glutathione reductase 
family and contains the conserved FAD binding domain. Although a complex 
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of PhzS bound to PCA has not been elucidated but its resemblance with other 
FAD-dependent monooxygenases like e.g. the well studied p-
hydroxybenzoate hydroxylase or PHBH allowed us to construct a model of 
PhzS in complex with its substrate. 
 
However the attempts to co-crystallise both the enzymes PhzM and PhzS with 
their respective substrates and products were unsuccessful so, from the 
crystallographic data obtained it was not possible to conclude the exact order 
of the reaction mechanism involved in the biosynthesis of pyocyanin. So, we 
carried out some biochemical assays involving APCI, to get an insight on the 
pathway. When both the enzymes were added with PCA in the reaction 
mixture with their respective substrates and cosubstrates pyocyanin was 
formed showing that both the enzymes were active. However, when the same 
experiment was carried out with single enzyme we couldn’t see any 
conversion of PCA so it was not possible to find the exact order of the 
reaction. But later other results in our lab suggested that reduced PCA is 
infact the product of PCA biosynthesis so we decided to use chemically 
reduced PCA using Na2S2O4 for studying the biosynthesis of pyocyanin. 
Further experiments showed that PhzS converted reduced PCA but PhzM 
didn’t have any effect on the reduced PCA at all implying that infact in the 
pyocyanin biosynthetic pathway enzyme PhzS catalyses the first step followed 
by PhzM. Thus, in addition to better understanding of the structures of the two 
enzymes involved in the pyocyanin biosynthesis we also have some idea 
about the pathway involved in the biosynthesis. 
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5.0 Zusammenfassung 
Phenazine sind eine Klasse von Sekundärmetaboliten, die das Interesse von 
Forschern seit Mitte des 19.ten Jahrhunderts auf sich gezogen haben. Unter 
allen phenazinproduzierenden Organismen ist Pseudomonas die am besten 
untersuchte Gattung. Die Biosynthese der Phenazine zweigt vom 
Shikimatweg ab. Neben dem sieben Gene enthaltenden Operon, das zur 
Biosynthese von Phenazine-1-carboxylat (PCA) führt, gibt es einige Gene, die 
an der Erzeugung von anderen Phenazinverbindungen beteiligt sind. Die 
Gene phzm und phzs sind hierfür ein Beispiel. Sie sind für die Umwandlung 
von PCA in Pyocyanin verantwortlich. Als Mitglied der großen 
Verbindungsklasse der Phenazine ist Pyocyanin toxisch für viele Prokaryoten 
und Säugetierzellen. Obwohl Pyocyanin bereits seit den frühen Jahren der 
Phenazinforschung untersucht wird, ist über die Enzyme, die an seiner 
Biosynthese beteiligt sind, nur sehr wenig bekannt. Die vorliegende Arbeit 
liefert einen Einblick in die Kristallstrukturen dieser Enzyme und gibt Hinweise 
auf die Reaktionsmechanismen der Pyocyaninbiosynthese. 
 
Die Struktur von PhzM wurde mit der SAD-Methode unter Verwendung von 
Selenomethionin-markiertem Protein gelöst. Das finale Modell von nativem 
PhzM wurde zu einer Auflösung von 1.8Å mit R = 13.9% und Rfree = 18.4% 
verfeinert. Wie andere Methyltransferasen besitzt PhzM eine SAM-
Bindungsstelle mit einer Rossmann-Faltung. PhzM ist den O-
Methyltransferasen aus Pflanzen am ähnlichsten, und die Topologie der SAM-
Bindungsstelle kategorisiert das Enzym als Klasse-I-Methyltransferase. Es 
wurde außerdem die Struktur von PhzM in Gegenwart des Cosubstrats SAM 
bestimmt. Ein Vergleich dieses Komplexes mit der apo-Struktur zeigt große 
strukturelle Veränderungen zwischen der offenen, unkomplexierten und der 
geschlossenen, SAM-komplexierten Struktur auf, aus denen ebenfalls ein 
besseres Verständnis über die Rolle der Methyltransferase PhzM in der 
Pyocyaninbiosynthese abgeleitet werden kann.  
 
Auch die Struktur von PhzS wurde mit der SAD-Methode aus 
Selenomethionin-markiertem Protein bestimmt. Das endgültige Strukturmodell 
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von PhzS wurde zu einer Auflösung von 2.4Å mit R = 20.3% und Rfree = 
22.9% verfeinert. Das Enzym PhzS weist eine Verwandtschaft zu p-
Hydroxybenzoat-Hydroxylase (PHBH) aus der Glutathion-Reduktase-Familie 
auf und enthält die konservierte FAD-bindende Domäne. Obwohl 
experimentell kein Komplex mit dem Substrat PCA hergestellt werden konnte, 
erlaubt die Ähnlichkeit zu PHBH die Modellierung eines solchen Komplexes.  
 
Da weder PhzM noch PhzS in Gegenwart ihrer Substrate oder Produkte 
kristallisiert werden konnten, war es nicht möglich anhand der 
kristallografischen Daten die Abfolge der Reaktionen der 
Pyocyaninbiosynthese zu bestimmen. Aus diesem Grund wurden 
biochemische Experimente, u.a. APCI-Massenspektrometrie, durchgeführt. 
Wenn PCA mit beiden Enzyme und ihren Cosubstraten gleichzeitig umgesetzt 
wurde, kam es zu einer schnellen Bildung von Pyocyanin, was zeigt, dass 
beide Enzyme aktiv sind. Wenn jedoch jeweils nur ein einzelnes Enzym 
eingesetzt wurde, konnte kein Umsatz von PCA beobachtet werden, so dass 
sich aus diesen Experimenten die Reihenfolge der Reaktionen in der 
Pyocyaninbiosynthese zunächst ebenfalls nicht feststellen ließ. Aus einem 
anderen Projekt der Arbeitsgruppe gab es jedoch Hinweise darauf, dass das 
Endprodukt der vorgelagerten PCA-Biosynthese reduziertes PCA ist. Es 
wurden daher weitere Experimente mit PhzM und PhzS sowie durch Na2S2O4 
reduziertem PCA durchgeführt. In diesen Experimenten konnte PhzS 
reduziertes PCA umsetzen, während PhzM keinen Effekt aufwies, was 
anzeigt, dass PhzS die erste und PhzM die zweite Umwandlung in der 
Pyocyaninbiosynthese katalysiert. Die vorliegende Arbeit trägt daher nicht nur 
zu einem besseren Verständnis der Strukturen von Enzymen in der 
Pyocyaninbiosynthese bei sondern liefert auch ein Modell für die Reihenfolge 
der Umsetzungen in diesem Biosyntheseweg. 
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6.0 Outlook 
 
While this study lays the groundwork for a detailed understanding of the 
conversion of PCA into pyocyanin by PhzS and PhzM, many details of the 
process still remain obscure. Most importantly, it is not clear why all attempts 
to form pyocyanin from 1-oh-phenazine were unsuccessful: neither (oxidised) 
commercial 1-oh-phenazine nor (reduced) 1-oh-phenazine formed from 
reduced PCA by PhzS were found to be substrates of PhzM. It is possible that 
these observations are due to special chemical properties of 1-oh-phenazine 
that have not been taken into account appropriately. For example, it is well 
known that 1-oh-phenazine polymerizes under certain conditions and that this 
tendency can be exploited to coat electrodes, which gives these electrodes 
certain electrochemical features (literature). From the results presented here, 
it can not be excluded that reduced 1-oh-phenazine, once formed from 
reduced PCA by PhzS, polymerises to a certain extend and is then not 
available for methylation if PhzM is added at a later stage. The 1-oh-
phenazine observed in HPLC-MS would then stem from back oxidation of the 
product, which is no longer a substrate of PhzM. The fact that it was not 
possible to observe a chemically reduced form of 1-oh-phenazine by HPLC-
MS may point into this direction. In the cell, this problem may not be relevant 
since both reactions are coupled, meaning that reduced 1-oh-phenazine 
produced by PhzS will be methylated to pyocyanin immediately without having 
time to polymerise or be back-oxidised. Further studies are required to assess 
these possibilities. 
For more detailed insight into structure/activity relationships, crystal 
complexes of the two enzymes with their substrates, products or analogues 
are desirable. For this, more robust crystallisation conditions would have to be 
established, especially for PhzS, which looses crystallisability quickly after 
purification. This may have to do with the redox-active cofactor FAD, which 
probably makes PhzS sensitive to both air and light. Crystallisation under oil 
and with properly degassed solutions in a dark container may alleviate this 
situation.  
Once residues that interact with ligands in the active centre have been 
identified, their importance should be studied by site-directed mutagenesis. 
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This also seems required in the light of exploiting PhzM and PhzS as targets 
in the development of novel pharmaceuticals, since the ability of both 
enzymes to escape the action of such agents by mutation and the 
concomitant emergence of resistance has to be assessed. 
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